[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"\"}":3,"_public_publisher_byId_83289c5a-0e1a-4089-90d0-8447ef02c8ba":656,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"totalCitation\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:83289c5a-0e1a-4089-90d0-8447ef02c8ba,\"}":671},{"meta":4,"data":6},{"total":5},"117",[7,60,176,207,299,413,445,480,543,572],{"id":8,"createTime":9,"updateTime":10,"relativeEntities":11,"slug":12,"properties":13,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":29,"subjectFields":30,"manageAffiliations":31,"indexDatabases":32,"url":33,"thumbnailPath":34,"statistic":35,"gsStatistic":26,"type":26,"analyzePriority":26},"5a09599f-54d1-44c3-8f16-3847ac552024","2023-08-17T04:28:50.832+00:00","2025-10-13T23:58:52.517+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Truy%E1%BB%81n-nhi%E1%BB%85m-Vi%E1%BB%87t-Nam",{"country":14,"issn":16,"introduce":18,"title":21},{"VOID":15},"VN",{"VOID":17},"08667829",{"EN":19,"VI":20},"{\"ops\":[{\"insert\":\"Vietnam Journal of Infectious Diseases is a social - professional forum of the Vietnam Society for Infectious Diseases, whose responsibility is to introduce the researches, the scientific advances in Vietnam and from the world; to contribute to the improvement of knowledges for health care staffs about clinic, treatment, guideline, prevention, epidemiology for infectious diseases, HIV\u002FAIDS and community health care; to provide, exchange and publish scientific information to the public accurately and promptly.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Vietnam Journal of Infectious Diseases publishes in the whole country; serves the professional work for researchers, clinical staffs, administrators, undergraduate and postgraduate students who are working and studying in the infections, tropical diseases and HIV\u002FAIDS from central to local levels, also organizations and individuals in the world who are interested in infectious and tropical diseases and prevention for HIV\u002FAIDS.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Editor in Chief:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Kinh. - Chairman of Editorial Board\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Mui.\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Headquarter:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Address:\"},{\"insert\":\" Level 6, National Hospital for Tropical Diseases, No. 78 Giai Phong Street, Dong Da District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tel:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913552672\"},\"insert\":\"0913552672\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"insert\":\".\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Bank account:\"},{\"insert\":\" 0021000275119, Vietcombank Hanoi Branch. Transaction office No. 7, 402 Tran Khat Chan, Hai Ba Trung District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Tạp chí Truyền nhiễm Việt Nam là cơ quan ngôn luận của Hội Truyền nhiễm Việt Nam, chịu sự lãnh đạo, chỉ đạo trực tiếp của Thường vụ Ban Chấp hành Hội Truyền nhiễm Việt Nam; sự kiểm tra, giám sát về nghiệp vụ báo chí của các cơ quan chức năng quản lý báo chí thuộc Bộ Thông tin và Truyền thông và Ban Tuyên giáo Trung ương Đảng.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí có trách nhiệm giới thiệu các công trình nghiên cứu khoa học, những tiến bộ khoa học trên thế giới và trong nước, góp phần nâng cao kiến thức khoa học cho cán bộ y tế về lâm sàng, điều trị, hướng dẫn, dự phòng, dịch tễ học các bệnh truyền nhiễm, HIV\u002FAIDS và chăm sóc sức khỏe cộng đồng; cung cấp, trao đổi, phổ biến các thông tin khoa học tới công chúng chính xác và kịp thời.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí xuất bản 03 tháng\u002F01 kỳ và được phát hành qua Bưu điện và tự phát hành trong phạm vi toàn quốc.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Lãnh đạo Tạp chí: \"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Tổng Biên tập: ThS.BSCKII Nguyễn Trung Cấp\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Phó Tổng Biên tập:\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"            TS.BSCKII Phạm Ngọc Thạch\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Trụ sở tòa soạn:\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Địa chỉ: Tầng 6, Bệnh viện Bệnh Nhiệt đới Trung ương, 78 đường Giải Phóng, phường Phương Mai, quận Đống Đa, thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Điện thoại:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\" - \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tài khoản:\"},{\"insert\":\" Số 0021000275119 Ngân hàng Ngoại thương Việt Nam, chi nhánh Hà Nội (Vietcombank Hà Nội). Phòng giao dịch số 7, 402 Trần Khát Chân, quận Hai Bà Trưng, Thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":22,"VI":23},"Vietnam Journal of Infectious Diseases","Tạp chí Truyền nhiễm Việt Nam","PUBLISHER","VERIFIED",null,"Admin update database","PENDING",51,[],[],[],"https:\u002F\u002Ftruyennhiemvietnam.vn\u002Findex.php\u002Fvjid","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F5a09599f-54d1-44c3-8f16-3847ac552024\u002Fadb0e52bf25e0de580fd4289519cb8bf.jpg",{"impactFactor":36,"impactFactorByYear":37,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":41,"totalPublicationByYear":42,"totalCitation":48,"totalCitationByYear":49,"totalCitationPerPublication":54,"totalCitationPerPublicationByYear":55,"hindexLast5Year":59,"hindex":59},0,{"2022":38,"2023":39,"2024":40},0.01,0.03,0.13,315,{"2020":43,"2021":44,"2022":45,"2023":46,"2024":47},63,58,57,65,72,43,{"2020":50,"2021":51,"2022":52,"2023":53},8,15,9,11,0.14,{"2020":40,"2021":56,"2022":57,"2023":58},0.26,0.16,0.17,3,{"id":61,"createTime":62,"updateTime":63,"relativeEntities":64,"slug":65,"properties":66,"entityType":24,"verifyStatus":25,"verifyTime":78,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":79,"subjectFields":80,"manageAffiliations":81,"indexDatabases":136,"url":137,"thumbnailPath":26,"statistic":138,"gsStatistic":155,"type":175,"analyzePriority":26},"25b6bd10-676c-40c0-8dc3-356d1679a284","2023-05-19T02:22:33.430+00:00","2026-06-18T23:33:57.141+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Y-D%C6%B0%E1%BB%A3c-h%E1%BB%8Dc-C%E1%BA%A7n-Th%C6%A1",{"country":67,"issn":68,"introduce":70,"title":73,"gsId":76},{"VOID":15},{"VOID":69},"23541210",{"EN":71,"VI":72},"\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">04\u002F10\u002F2015 Ministry of Information and Communications allowed Can Tho journal of medicine and pharmacy to operate (102 \u002FGP-BTTTT)\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">07\u002F16\u002F2015 Can Tho journal of medicine and pharmacy is internationally recognized: ISSN 2354-1210\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">In 2016, The journal has been included in the list of medical science journals by The State Council for professorship which is awarded a work score of 0-0.5 points for a published article.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Can Tho Journal of Medicine and Pharmacy welcome original works that haven’t been submitted or published in other medical journals. Posts must contain content related to one of the journal’s categories.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The content published\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The journal is divided into 3 categories:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Scientific research article: are valuable scientific works, which have been researched and accepted.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Overview of medicine, biology and pharmacy: serving the objective of continuing training in the fields of medicine, biology and pharmacy; to systematize classical and modern knowledge.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Update information on new knowledge about medicine, biology, pharmacy in the country and in the world.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Scope\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Publication and introduction of scientific research in the fields:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Medicine (internal medicine, surgery, pediatrics, obstetrics and gynecology, odonto-stomatology, laboratory, oncology, traditional medicine, nursing).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Biology (genetics, biotechnology).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Pharmacology (pharmaceutics, drug quality analysis-control, synthetic pharmaceutical chemistry, biochemistry, pharmacognosy, botany, clinical pharmacy).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- To enhance the quality of undergraduate, postgraduate education, scientifically researching and meet the necessary treatment in hospital.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Introducing the updated domestic and oversea information about science technology to promote scientific research and exchanging technology in local, other universities.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Exchanging pharmaceutical and medical information for social health developing in the Mekong Delta and Vietnam.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The object\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Postgraduate students, student of Can Tho University of Medicine and Pharmacy, scientists from schools, research institutes, hospitals, health centers, pharmaceutical companies of the Mekong Delta; other provinces and regions in Vietnam and other country.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Address\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Headquarters of Can Tho Journal of Medicine and Pharmacy, located Scientific Research and International Cooperation Office: 179 Nguyen Van Cu Street, An Khanh Ward, Ninh Kieu District, Can Tho City, Vietnam.\u003C\u002Fspan>\u003C\u002Fp>","\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Ngày 16\u002F7\u002F2015, Tạp chí Y Dược học Cần Thơ được cấp chỉ số quốc tế: ISSN 2354-1210.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 4\u002F2016, Tạp chí đã được Hội đồng Giáo sư ngành Y đưa vào danh sách các tạp chí khoa học Y học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Năm 2020 Tạp chí Y Dược học Cần Thơ đã được phê duyệt vào danh mục của các Hội đồng Giáo sư ngành Dược học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ ra 12 số\u002Fnăm, 180-200 trang\u002Fsố.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 12\u002F2022 Tạp chí Y Dược học Cần Thơ là thành viên của hệ thống Crossref và từ tháng 01\u002F2023 tạp chí thực hiện bình duyệt online kín 2 chiều nhằm tăng tính minh bạch, tin cậy của các công trình nghiên cứu khoa học và đảm bảo tốt nhất chất lượng khoa học của bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ, mục đích và phạm vi của tạp chí\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ và mục đích hoạt động của tạp chí: xuất bản nhằm mục đích phổ biến kết quả từ các đề tài nghiên cứu khoa học; giao lưu trao đổi khoa học, chia sẻ kinh nghiệm, học tập, đồng thời cập nhật thông tin khoa học mới trong các lĩnh vực y, sinh, dược học trong và ngoài nước.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phạm vi của tạp chí: Tạp chí xuất bản được chia thành 3 chuyên mục: (i) Bài báo nghiên cứu khoa học là kết quả công trình nghiên cứu khoa học có giá trị đã được triển khai nghiên cứu, (ii) Bài tổng quan y, sinh, dược học: phục vụ mục tiêu đào tạo liên tục trong lĩnh vực y, sinh, dược học; nhằm hệ thống hóa những kiến thức kinh điển và hiện đại; (iii) Thông tin cập nhật kiến thức mới về y, sinh, dược học trong nước và trên thế giới.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Chính sách truy cập mở\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ áp dụng chính sách truy cập mở đối với các bài báo đã xuất bản đến với độc giả, nhằm mở rộng cơ hội tiếp cận các kết quả nghiên cứu chất lượng cao và tăng cường trao đổi kiến thức. Tạp chí đăng tải trực tuyến (miễn phí) toàn văn các bài báo được công bố trên website của Tạp chí (https:\u002F\u002Ftapchi.ctump.edu.vn).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đạo đức xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ cam kết tuân thủ đạo đức xuất bản phù hợp với các hướng dẫn và tiêu chuẩn của the Committee on Publication Ethics (COPE), tuân thủ các nguyên tắc của COPE’s Core Practices, Best Practices Guidelines for Journal Editors và Guidelines on Good Publication Practices.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Bản thảo bài báo chỉ được chấp nhận khi được tác giả chịu trách nhiệm chính cam kết các nội dung sau: Các nội dung của bản thảo chưa được đăng tải toàn bộ hoặc một phần ở các tạp chí khác; Tất cả các tác giả đều có đóng góp một cách đáng kể vào quá trình nghiên cứu hoặc chuẩn bị bản thảo và cùng chịu trách nhiệm về các nội dung của bản thảo; Tuân thủ các biện pháp đảm bảo đạo đức nghiên cứu (ví dụ thỏa thuận đồng ý tham gia nghiên cứu).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Cam kết bảo mật\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí cam kết thực hiện và tuân thủ các quy định của luật và các văn bản hướng dẫn liên quan đến bảo mật thông tin cá nhân trên không gian mạng. Các thông tin mà người dùng (tác giả, độc giả, biên tập viên, người phản biện) nhập vào các biểu mẫu trên Hệ thống Quản lý xuất bản trực tuyến của tạp chí chỉ được sử dụng vào các mục đích đã được tuyên bố rõ ràng và sẽ không được cung cấp cho bất kỳ bên thứ ba nào khác, hay dùng vào bất kỳ mục đích nào khác.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phí gửi bài\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng bài: 1.000.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng nhanh: 1.500.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với tác giả là cán bộ viên chức thuộc Trường Đại học Y Dược Cần Thơ thì được hỗ trợ 50% lệ phí gửi đăng bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với sinh viên thực hiện đề tài nghiên cứu khoa học cấp trường được hỗ trợ 100% lệ phí đăng bài ( Tác giả gửi đính kèm “ Quyết định về việc giao tổ chức thực hiện đề tài nghiên cứu khoa học cấp Trường của sinh viên”).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Hình thức nộp lệ phí:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Tiền mặt:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Nộp trực tiếp tại Phòng Tài chính - Kế toán, Trường Đại học Y Dược Cần Thơ, số 179 Nguyễn Văn Cừ, P. An Khánh, Q. Ninh Kiều, thành phố Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Chuyển khoản:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tên Tài khoản: Trường ĐHYD Cần Thơ, Số TK: 0111000115668, tại ngân hàng Vietcombank chi nhánh Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Thời gian: Áp dụng từ ngày 01\u002F02\u002F2023.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">* Phí gửi bài không được hoàn trả khi bài viết bị từ chối hoặc tác giả xin rút bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Quy trình phản biện bài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ thực hiện quy trình phản biện kín hai chiều nghiêm ngặt. Danh tính của những người phản biện không được tiết lộ cho các tác giả và ngược lại. Quy trình thẩm định bài báo đăng gồm các bước sau:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tiếp nhận bản thảo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tác giả liên hệ gửi bản thảo đến Tạp chí qua hệ thống trực tuyến tại website: https:\u002F\u002Ftapchi.ctump.edu.vn. Hướng dẫn về cách đăng ký, gửi bài và chuẩn bị bản thảo được cung cấp trên website của Tạp chí.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sàng lọc sơ bộ\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sau khi Tòa soạn nhận được bài báo của tác giả, Ban Thư ký sẽ tiến hành kiểm tra sơ bộ bài báo (các yêu cầu về nội dung và hình thức). Những bài báo không đúng quy cách hoặc có nội dung không phù hợp hoặc vi phạm bản quyền sẽ bị từ chối (Ban Thư ký thông báo phản hồi đến tác giả trong vòng 1 tuần). Những bài báo đủ điều kiện, được Ban Thư ký tòa soạn chuyển đến Ban Biên tập có cùng chuyên môn với nội dung bài báo để đề xuất người phản biện. Thời gian kể từ khi Ban Biên tập nhận bài báo đến khi đề xuất người phản biện bài báo chậm nhất là 5 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Vòng phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký gửi bài và yêu cầu phản biện đến 02 phản biện độc lập.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Các phản biện gởi nhận xét cho Ban Thư ký. Thời gian từ khi gửi bài cho phản biện đến khi nhận ý kiến của phản biện tối đa là 20 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xử ký kết quả phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Nếu ý kiến đồng ý cho đăng và không cần chỉnh sửa, Ban Thư ký tiếp tục đăng bài theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Nếu ý kiến đồng ý đăng và cần chỉnh sửa, Ban Thư ký sẽ thông tin đến tác giả chỉnh sửa theo yêu cầu của người phản biện. Thời gian chỉnh sửa và gửi lại kéo dài không quá 2 tuần, từ khi tác giả bài báo nhận được thông tin (Quá trình này có thể lặp lại tối đa 2 lần\u002F1 bài báo). Khi có sự thống nhất, đồng ý của người phản biện; bài báo được tiếp tục đăng theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Những bài báo có chất lượng không đạt yêu cầu, cả 2 phản biện không đồng ý cho đăng sẽ bị Tòa soạn từ chối đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký tổng hợp các bản thảo đã được tác giả hoàn thiện sau thẩm định trình Ban Biên tập xem xét, Tổng Biên tập phê duyệt, quyết định bài đăng theo các tiêu chí: sự phù hợp nội dung với tôn chỉ và mục đích, thể loại bài viết (ưu tiên các bài có bài có nghiên cứu chuyên sâu, hàm lượng khoa học cao), đóng góp mới bài báo, bài báo được ưu tiên đăng trong số gần nhất của Tạp chí theo thứ tự: tính thời sự, chất lượng bài báo và thời gian gửi bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Ban Biên tập và Ban Thư ký biên tập bản thảo, chế bản, đọc rà soát lỗi. Thời gian hoàn thành từ 10-15 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Ban Thư ký có trách nhiệm thông báo cho tác giả bài báo (bằng e-mail) về tình hình phê duyệt bài báo, thời gian, số kỳ, tập xuất bản bài báo theo qui định.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">4. Danh sách bài báo theo số Tạp chí được in ấn và phát hành trong năm định kỳ được công bố chính thức trên website: https:\u002F\u002Ftapchi.ctump.edu.vn\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>",{"EN":74,"VI":75},"Cantho Journal of Medicine and Pharmacy","Tạp chí Y Dược học Cần Thơ",{"VOID":77},"wcQ1uqwAAAAJ","2023-05-30T08:17:21.868+00:00",32,[],[82],{"id":83,"createTime":84,"updateTime":85,"relativeEntities":86,"slug":87,"properties":88,"entityType":98,"verifyStatus":25,"verifyTime":99,"verifyNote":26,"syncStatus":28,"languages":100,"translateLanguages":26,"viewCount":103,"url":104,"parentIds":105,"statistic":106},"6413896b-eca9-442b-a73f-182a58a0ce40","2023-06-12T14:59:13.446+00:00","2026-06-19T02:29:32.871+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Y-D%C6%B0%E1%BB%A3c-C%E1%BA%A7n-Th%C6%A1",{"country":89,"title":90,"address":93,"abbreviation":96},{"VOID":15},{"EN":91,"VI":92},"Can Tho University of Medicine and Pharmacy","Trường Đại học Y Dược Cần Thơ",{"VI":94,"EN":95},"Số 179, đường Nguyễn Văn Cừ, phường An Khánh, quận Ninh Kiều, thành phố Cần Thơ, Việt Nam","No 179, Nguyen Van Cu street, An Khanh ward, Ninh Kieu district, Can Tho city, Vietnam",{"VOID":97},"ctump","AFFILIATION","2023-08-01T14:07:27.977+00:00",[101,102],"VI","EN",12,"http:\u002F\u002Fwww.ctump.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":107,"i10Index":111,"i10IndexLast5Year":59,"totalPublication":112,"totalPublicationByYear":113,"totalCitation":122,"totalCitationByYear":123,"totalCitationPerPublication":128,"totalCitationPerPublicationByYear":129,"hindexLast5Year":135,"hindex":135},{"2022":108,"2023":109,"2024":110,"2025":38},0.1,0.05,0.07,4,1489,{"2013":114,"2014":115,"2015":115,"2016":111,"2017":115,"2018":59,"2019":114,"2020":116,"2021":117,"2022":118,"2023":119,"2024":120,"2025":121,"2026":111},2,1,10,84,281,680,260,156,313,{"2013":59,"2014":114,"2018":124,"2021":125,"2022":126,"2023":127},17,36,123,132,0.21,{"2013":130,"2014":114,"2018":131,"2021":132,"2022":133,"2023":134},1.5,5.67,0.43,0.44,0.19,6,[],"https:\u002F\u002Ftapchi.ctump.edu.vn\u002Findex.php\u002Fctump",{"impactFactor":36,"impactFactorByYear":139,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":140,"totalPublicationByYear":141,"totalCitation":147,"totalCitationByYear":148,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":152,"hindexLast5Year":135,"hindex":135},{"2022":38,"2023":36,"2024":39,"2025":38},1956,{"0":114,"2019":114,"2020":50,"2021":142,"2022":143,"2023":144,"2024":145,"2025":146},76,403,789,305,371,524,{"0":114,"2019":135,"2021":124,"2022":149,"2023":150,"2024":111,"2025":114},287,206,0.27,{"0":115,"2019":59,"2021":153,"2022":154,"2023":56,"2024":38,"2025":38},0.22,0.71,{"impactFactor":26,"impactFactorByYear":26,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":156,"totalPublicationByYear":157,"totalCitation":163,"totalCitationByYear":164,"totalCitationPerPublication":169,"totalCitationPerPublicationByYear":170,"hindexLast5Year":135,"hindex":135},461,{"0":158,"2019":114,"2021":159,"2022":160,"2023":161,"2024":158,"2025":162},7,37,296,107,5,419,{"2021":59,"2022":59,"2023":165,"2024":166,"2025":167,"2026":168},71,126,171,41,0.91,{"2021":171,"2022":38,"2023":172,"2024":173,"2025":174},0.08,0.66,18,34.2,"JOURNAL",{"id":177,"createTime":178,"updateTime":179,"relativeEntities":180,"slug":181,"properties":182,"entityType":24,"verifyStatus":25,"verifyTime":193,"verifyNote":26,"syncStatus":28,"languages":194,"translateLanguages":26,"viewCount":36,"subjectFields":195,"manageAffiliations":196,"indexDatabases":197,"url":198,"thumbnailPath":26,"statistic":26,"gsStatistic":199,"type":175,"analyzePriority":26},"f8d0bf97-8d89-482e-b58c-2fc481a0b79b","2025-10-27T06:27:08.591+00:00","2026-06-18T23:33:41.667+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-v%C3%A0-C%C3%B4ng-ngh%E1%BB%87-nhi%E1%BB%87t-%C4%91%E1%BB%9Bi",{"country":183,"introduce":184,"gsId":186,"title":188,"issn":191},{"VOID":15},{"EN":185},"\u003Cp style=\"text-align:justify;\">     Journal of Tropical Science and Engineering (JTSE) is a multidisciplinary scientific journal, licensed to operate as a print journal in 2012 and an electronic journal in 2024 (License No.1479\u002FGP-BTTTT dated August 20, 2012 and No.91\u002FGP-BTTTT dated April 9, 2024 issued by the Ministry of Information and Communications of Vietnam). The JTSE is headquartered in Hanoi.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">        The JTSE is published every 3 months (4 issues\u002Fyear), publishing research results and overview articles in 3 groups of fields: Tropical Ecology and Environment; Chemistry and Material Sciences; Biomedicine and Pharmacy. In 2022, the JTSE registered the international identifier Digital Object Identifier (DOI): 10.58334\u002Fvrtc.jtst and assigned DOI codes to all articles of the journal. The members of the Editorial Board of the JTSE are prestigious scientists and leading scientists from Vietnam and many countries in the world. The JTSE has been recognized by the Vietnam State Council for Professorship to score scientific articles in Chemistry, Medicine and Biology with scores ranging from 0-0.75 points.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">      Currently, the JTSE is building and perfecting a set of criteria and making efforts to join the List of prestigious  international journals with a roadmap to enter Scopus and SCIE in the coming time.\u003C\u002Fp>",{"VOID":187},"MS2_GJQAAAAJ",{"VI":189,"EN":190},"Tạp chí Khoa học và Công nghệ nhiệt đới","Journal of Tropical Science and Engineering",{"VOID":192},"08667535","2025-10-27T06:27:25.058+00:00",[101,102],[],[],[],"https:\u002F\u002Ftapchikhcnnd.com.vn",{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":200,"totalPublicationByYear":201,"totalCitation":161,"totalCitationByYear":203,"totalCitationPerPublication":153,"totalCitationPerPublicationByYear":205,"hindexLast5Year":114,"hindex":114},481,{"0":115,"2020":115,"2021":115,"2022":114,"2024":115,"2025":202,"2026":115},474,{"2017":114,"2018":115,"2019":111,"2020":162,"2021":162,"2022":116,"2023":50,"2024":162,"2025":204,"2026":52},52,{"2020":162,"2021":162,"2022":162,"2024":162,"2025":206,"2026":52},0.11,{"id":208,"createTime":209,"updateTime":210,"relativeEntities":211,"slug":212,"properties":213,"entityType":24,"verifyStatus":25,"verifyTime":221,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"subjectFields":223,"manageAffiliations":224,"indexDatabases":225,"url":226,"thumbnailPath":26,"statistic":227,"gsStatistic":276,"type":175,"analyzePriority":26},"a3d1e82a-57e2-40f9-940e-f5fa8b9ef64a","2023-06-01T07:11:26.039+00:00","2026-06-18T23:33:28.573+00:00",[],"VNU-Journal-of-Science-Earth-and-Environmental-Sciences",{"issn":214,"title":216,"country":218,"gsId":219},{"VOID":215},"26159279",{"EN":217},"VNU Journal of Science: Earth and Environmental Sciences",{"VOID":15},{"VOID":220},"UmXD8vEAAAAJ","2023-06-01T07:17:59.210+00:00",27,[],[],[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FEES",{"impactFactor":36,"impactFactorByYear":228,"i10Index":234,"i10IndexLast5Year":36,"totalPublication":235,"totalPublicationByYear":236,"totalCitation":246,"totalCitationByYear":247,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":262,"hindexLast5Year":103,"hindex":103},{"2010":229,"2012":40,"2013":230,"2014":230,"2015":231,"2016":54,"2017":171,"2018":109,"2019":110,"2020":57,"2021":232,"2022":233,"2023":151,"2024":58},0.02,0.04,0.09,0.31,0.4,19,656,{"2008":237,"2009":238,"2010":239,"2011":238,"2012":240,"2013":241,"2014":239,"2015":242,"2016":243,"2017":244,"2018":245,"2019":165,"2020":125,"2021":168,"2022":125,"2023":222,"2024":111},23,24,22,28,25,20,146,29,78,1038,{"2008":248,"2009":249,"2010":250,"2011":251,"2012":252,"2013":253,"2014":254,"2015":255,"2016":256,"2017":257,"2018":161,"2019":258,"2020":259,"2021":29,"2022":260},119,64,66,86,38,73,59,31,129,39,97,53,26,1.58,{"2008":263,"2009":264,"2010":59,"2011":265,"2012":266,"2013":267,"2014":268,"2015":269,"2016":270,"2017":271,"2018":272,"2019":272,"2020":273,"2021":274,"2022":275},5.17,2.67,3.58,1.36,2.92,2.68,1.55,0.88,1.34,1.37,1.47,1.24,0.72,{"impactFactor":26,"impactFactorByYear":26,"i10Index":173,"i10IndexLast5Year":135,"totalPublication":277,"totalPublicationByYear":278,"totalCitation":279,"totalCitationByYear":280,"totalCitationPerPublication":288,"totalCitationPerPublicationByYear":289,"hindexLast5Year":158,"hindex":298},113,{"2007":114,"2008":103,"2009":173,"2010":116,"2011":51,"2012":239,"2013":103,"2014":162,"2015":53,"2016":135},616,{"2009":162,"2010":114,"2011":52,"2012":124,"2013":222,"2014":255,"2015":48,"2016":44,"2017":281,"2018":282,"2019":259,"2020":283,"2021":284,"2022":285,"2023":286,"2024":257,"2025":287,"2026":59},54,60,49,47,34,44,33,5.45,{"2009":290,"2010":291,"2011":292,"2012":293,"2013":294,"2014":295,"2015":296,"2016":297},0.28,0.2,0.6,0.77,2.25,6.2,3.91,9.67,14,{"id":300,"createTime":301,"updateTime":302,"relativeEntities":303,"slug":304,"properties":305,"entityType":24,"verifyStatus":25,"verifyTime":316,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":234,"subjectFields":317,"manageAffiliations":318,"indexDatabases":388,"url":389,"thumbnailPath":390,"statistic":391,"gsStatistic":409,"type":175,"analyzePriority":26},"a7166325-6c9e-4db3-8a59-7c879701a372","2023-07-31T04:28:49.231+00:00","2026-06-18T23:33:22.428+00:00",[],"VNU-Journal-of-Science-Policy-and-Management-Studies",{"country":306,"issn":307,"eissn":309,"title":311,"gsId":314},{"VOID":15},{"VOID":308},"26159295",{"VOID":310},"25881116",{"EN":312,"VI":313},"VNU Journal of Science: Policy and Management Studies","Tạp chí Nghiên cứu Chính sách và Quản lý",{"VOID":315},"xKW2E_cAAAAJ","2023-08-01T03:23:46.688+00:00",[],[319],{"id":320,"createTime":321,"updateTime":322,"relativeEntities":323,"slug":324,"properties":325,"entityType":98,"verifyStatus":25,"verifyTime":335,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":336,"url":337,"parentIds":338,"statistic":339},"12466116-8f60-4b01-8faf-2411483a0977","2023-05-30T09:37:38.472+00:00","2026-06-19T02:14:28.352+00:00",[],"Vietnam-National-University",{"country":326,"title":327,"abbreviation":330,"address":332},{"VOID":15},{"EN":328,"VI":329},"Vietnam National University, Hanoi","Đại học Quốc gia Hà Nội",{"VOID":331},"VNU",{"VI":333,"EN":334},"Số 144 Xuân Thủy, Phường Dịch Vọng Hậu, Quận Cầu Giấy, Hà Nội, Việt Nam","No. 144 Xuan Thuy Street, Dich Vong Hau Ward, Cau Giay District, Hanoi, Vietnam","2023-08-02T13:58:17.029+00:00",16,"http:\u002F\u002Fwww.vnu.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":340,"i10Index":285,"i10IndexLast5Year":162,"totalPublication":344,"totalPublicationByYear":345,"totalCitation":354,"totalCitationByYear":355,"totalCitationPerPublication":368,"totalCitationPerPublicationByYear":369,"hindexLast5Year":336,"hindex":336},{"2014":109,"2015":231,"2016":231,"2017":206,"2018":341,"2019":110,"2020":342,"2021":343,"2022":171,"2023":231,"2024":110,"2025":39},0.06,0.18,0.35,1247,{"2003":115,"2004":115,"2005":114,"2006":59,"2007":111,"2008":162,"2009":59,"2010":50,"2011":124,"2012":336,"2013":260,"2014":244,"2015":250,"2016":281,"2017":346,"2018":347,"2019":348,"2020":349,"2021":350,"2022":351,"2023":352,"2024":353,"2025":255,"2026":50},94,88,83,67,176,185,187,93,1644,{"2004":111,"2005":115,"2006":52,"2007":298,"2008":356,"2009":298,"2010":286,"2011":357,"2012":244,"2013":358,"2014":359,"2015":360,"2016":361,"2017":362,"2018":363,"2019":364,"2020":365,"2021":366,"2022":367,"2023":367,"2024":162},13,81,48,70,151,115,109,259,174,181,121,101,1.32,{"2004":111,"2005":370,"2006":59,"2007":371,"2008":372,"2009":373,"2010":374,"2011":375,"2012":376,"2013":377,"2014":378,"2015":379,"2016":380,"2017":381,"2018":382,"2019":383,"2020":384,"2021":385,"2022":386,"2023":387,"2024":109},0.5,3.5,2.6,4.67,5.5,4.76,1.81,1.85,2.41,2.29,2.13,1.16,2.94,2.1,2.7,0.69,0.55,0.54,[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FPaM","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002Fa7166325-6c9e-4db3-8a59-7c879701a372\u002Fecfe83f4bcc60c7023ae04d8900fe0ac.jpg",{"impactFactor":36,"impactFactorByYear":392,"i10Index":111,"i10IndexLast5Year":36,"totalPublication":394,"totalPublicationByYear":395,"totalCitation":399,"totalCitationByYear":400,"totalCitationPerPublication":293,"totalCitationPerPublicationByYear":403,"hindexLast5Year":158,"hindex":158},{"2018":109,"2019":171,"2020":393,"2021":108,"2022":54,"2023":206,"2024":54},0.23,320,{"2015":50,"2016":239,"2017":286,"2018":396,"2019":397,"2020":159,"2021":398,"2022":168,"2023":79,"2024":255},30,35,40,247,{"2015":115,"2016":242,"2017":401,"2018":222,"2019":402,"2020":79,"2021":239,"2022":50,"2023":116},77,50,{"2015":404,"2016":169,"2017":405,"2018":406,"2019":407,"2020":408,"2021":386,"2022":291,"2023":232},0.12,1.75,0.9,1.43,0.86,{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":103,"totalPublicationByYear":410,"totalCitation":234,"totalCitationByYear":411,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":412,"hindexLast5Year":114,"hindex":59},{"2015":114,"2016":116},{"2016":115,"2017":114,"2018":114,"2019":59,"2020":114,"2021":59,"2022":114,"2023":114,"2024":115,"2026":115},{"2016":108},{"id":414,"createTime":415,"updateTime":416,"relativeEntities":417,"slug":418,"properties":419,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":238,"subjectFields":428,"manageAffiliations":429,"indexDatabases":430,"url":431,"thumbnailPath":26,"statistic":432,"gsStatistic":438,"type":175,"analyzePriority":26},"16e65a3f-d274-47dd-8691-56d76eb58c3d","2023-05-30T09:10:06.062+00:00","2026-06-18T23:33:17.679+00:00",[],"Vietnam-Journal-of-Otorhinolaryngology-Head-and-Neck-Surgery",{"country":420,"issn":421,"title":423,"gsId":426},{"VOID":15},{"VOID":422},"18593704",{"EN":424,"VI":425},"Vietnam Journal of Otorhinolaryngology - Head and Neck Surgery","Tạp chí Tai Mũi Họng Việt Nam",{"VOID":427},"L78B_eIAAAAJ",[],[],[],"https:\u002F\u002Ftapchitaimuihong.vn\u002Findex.php\u002Ftmh",{"impactFactor":36,"impactFactorByYear":433,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":434,"totalPublicationByYear":435,"totalCitation":111,"totalCitationByYear":436,"totalCitationPerPublication":230,"totalCitationPerPublicationByYear":437,"hindexLast5Year":115,"hindex":115},{"2024":229},95,{"2022":52,"2023":286,"2024":255,"2025":53},{"2023":111},{"2023":231},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":240,"totalPublicationByYear":439,"totalCitation":234,"totalCitationByYear":440,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":442,"hindexLast5Year":114,"hindex":114},{"2023":53,"2024":116,"2025":135,"2026":115},{"2024":59,"2025":298,"2026":114},0.68,{"2024":443,"2025":444,"2026":114},0.3,2.33,{"id":446,"createTime":447,"updateTime":448,"relativeEntities":449,"slug":450,"properties":451,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":396,"subjectFields":460,"manageAffiliations":461,"indexDatabases":462,"url":463,"thumbnailPath":464,"statistic":465,"gsStatistic":472,"type":175,"analyzePriority":26},"25988add-c322-4eda-afda-63b1559bb824","2023-04-07T03:49:55.817+00:00","2026-06-18T23:32:23.776+00:00",[],"T%E1%BA%A1p%20ch%C3%AD%20Y%20-%20D%C6%B0%E1%BB%A3c%20h%E1%BB%8Dc%20qu%C3%A2n%20s%E1%BB%B1",{"country":452,"issn":453,"title":455,"gsId":458},{"VOID":15},{"VOID":454},"18590748",{"EN":456,"VI":457},"Journal of Military Pharmaco-medicine","Tạp chí Y - Dược học quân sự",{"VOID":459},"_pmQ8IEAAAAJ",[],[],[],"https:\u002F\u002Fjmpm.vn\u002Findex.php\u002Fjmpm","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F25988add-c322-4eda-afda-63b1559bb824\u002F09c6bc42157cf5ece95edc971ccddb52.jpg",{"impactFactor":36,"impactFactorByYear":466,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":467,"totalPublicationByYear":468,"totalCitation":135,"totalCitationByYear":470,"totalCitationPerPublication":38,"totalCitationPerPublicationByYear":471,"hindexLast5Year":115,"hindex":115},{"2023":229,"2024":38},475,{"2022":168,"2023":365,"2024":469,"2025":124},236,{"2022":114,"2023":111},{"2022":109,"2023":229},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":277,"totalPublicationByYear":473,"totalCitation":401,"totalCitationByYear":474,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":475,"hindexLast5Year":59,"hindex":59},{"2015":115,"2018":114,"2019":115,"2020":115,"2021":59,"2022":103,"2023":159,"2024":287,"2025":237},{"2020":115,"2021":115,"2022":115,"2023":52,"2024":237,"2025":79,"2026":116},{"2020":115,"2021":476,"2022":171,"2023":477,"2024":478,"2025":479},0.33,0.24,0.7,1.39,{"id":481,"createTime":482,"updateTime":483,"relativeEntities":484,"slug":485,"properties":486,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":496,"translateLanguages":26,"viewCount":45,"subjectFields":497,"manageAffiliations":498,"indexDatabases":525,"url":526,"thumbnailPath":527,"statistic":528,"gsStatistic":26,"type":26,"analyzePriority":26},"2b8d7b12-2d20-4777-be98-077f44f03c69","2023-09-07T07:40:58.286+00:00","2025-07-13T21:21:00.542+00:00",[],"VNU-Journal-of-Social-Sciences-and-Humanities",{"country":487,"issn":488,"introduce":490,"title":493},{"VOID":15},{"VOID":489},"23541172",{"EN":491,"VI":492},"{\"ops\":[{\"insert\":\"VNU Journal of Social Sciences and Humanities (ISSN 2354-1172) is a double-blind peer-reviewed journal published by University of Social Sciences and Humanities, Vietnam National University, Hanoi, Vietnam, under the publication permit no. 155\u002FGP-BTTTT, issued on 11\"},{\"attributes\":{\"script\":\"super\"},\"insert\":\"th \"},{\"insert\":\"May, 2015 by Ministry of Information and Communications. The journal publishes four Vietnamese issues and two English issues per year.\\nCurrently, there are 35 reputable professors in the editorial board. The main objectives of the journal include: providing an intellectual platform for Vietnamese and international scholars; promoting interdisciplinary studies in social sciences and humanities; becoming the leading journal in social sciences and humanities in Vietnam; being indexed by worldwide databases and having academic recognition internationally in the near future.\\nThe journal is currently indexed by Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services and Vietnam National University’s digital archive.\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Journal of Social Sciences and Humanities-Vietnam\"},{\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"ISSN 2354-1172, email: tapchikhxhnv@gmail.com, tckhxhnv@vnu.edu.vn\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Được thành lập ngày 31\u002F8\u002F2015 (giấy phép hoạt động số 155\u002FGP-BVHTT ngày 11 tháng 5 năm 2015 của Bộ Thông tin và Truyền thông, mã số tiêu chuẩn quốc tế ISSN 2354-1172), Tạp chí Khoa học Xã hội và Nhân văn (Journal of Social Sciences and Humanities) là ấn phẩm khoa học chính thức, duy nhất của Trường Đại học Khoa học Xã hội và Nhân văn, ĐHQG Hà Nội, phát triển và kế thừa Chuyên san Khoa học Xã hội và Nhân văn, Tạp chí Khoa học, ĐHQG Hà Nội.\\nTạp chí xuất bản định kỳ (04 số tiếng Việt\u002Fnăm và 02 số tiếng Anh\u002Fnăm), có nhiệm vụ \"},{\"attributes\":{\"italic\":true},\"insert\":\"công bố, giới thiệu các công trình nghiên cứu khoa học khoa học xã hội và nhân văn của các tác giả là các nhà khoa học trong và ngoài nước, phục vụ giảng dạy, học tập và nghiên cứu khoa học\"},{\"insert\":\". Hội đồng biên tập của Tạp chí hiện bao gồm 33 nhà khoa học có uy tín trong nước và quốc tế. Tạp chí tập trung và ưu tiên đăng tải những bài báo theo định hướng của tinh thần cởi mở, sáng tạo, nhanh chóng vươn lên để tiếp cận và sánh ngang với các tạp chí có uy tín hàng đầu của khu vực và trên thế giới. Nội dung chính của Tạp chí bao gồm các Bài nghiên cứu (khoảng 6000 đến 15000 từ), các bài điểm sách, thông tin khoa học (khoảng 300 đến 1500 từ) được trình bày theo đúng cấu trúc và chuẩn mực của một tạp chí khoa học.\\nCác bài viết của Tạp chí hiện đang được trích dẫn bởi Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services.\\nMọi thông tin xin liên hệ: \"},{\"attributes\":{\"italic\":true},\"insert\":\"Phòng Tạp chí, 701 - E, Trường Đại học Khoa học Xã hội và Nhân văn, 336 Nguyễn Trãi, Thanh Xuân, Hà Nội. ĐT: 024.35581984; email: tckhxhnv@vnu.edu.vn \"},{\"insert\":\"hoặc \"},{\"attributes\":{\"italic\":true},\"insert\":\"tapchikhxhnv@gmail.com \"},{\"insert\":\"\\n\"}]}",{"EN":494,"VI":495},"VNU Journal of Social Sciences and Humanities","Tạp chí Khoa học Xã hội và Nhân văn",[101,102],[],[499],{"id":500,"createTime":501,"updateTime":502,"relativeEntities":503,"slug":504,"properties":505,"entityType":98,"verifyStatus":25,"verifyTime":509,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"url":26,"parentIds":510,"statistic":511},"8b6e349b-0daf-4895-9c3f-85f30f1bfd42","2023-07-31T12:55:58.430+00:00","2026-06-19T02:30:07.899+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Khoa-h%E1%BB%8Dc-X%C3%A3-h%E1%BB%99i-v%C3%A0-Nh%C3%A2n-v%C4%83n-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-H%C3%A0-N%E1%BB%99i",{"title":506},{"EN":507,"VI":508},"VNU University of Social Sciences and Humanities","Trường Đại học Khoa học Xã hội và Nhân văn, Đại học Quốc gia Hà Nội","2023-08-02T15:28:49.057+00:00",[],{"impactFactor":36,"impactFactorByYear":512,"i10Index":59,"i10IndexLast5Year":115,"totalPublication":514,"totalPublicationByYear":515,"totalCitation":518,"totalCitationByYear":519,"totalCitationPerPublication":520,"totalCitationPerPublicationByYear":521,"hindexLast5Year":162,"hindex":162},{"2016":229,"2017":230,"2018":229,"2021":230,"2022":58,"2023":513,"2024":38},0.15,365,{"2013":115,"2014":158,"2015":125,"2016":252,"2017":44,"2018":516,"2019":286,"2020":396,"2021":259,"2022":517,"2023":396,"2024":115,"2025":59,"2026":115},21,42,169,{"2015":283,"2016":135,"2017":52,"2018":50,"2019":298,"2020":53,"2021":359,"2022":115,"2023":115},0.46,{"2015":266,"2016":57,"2017":57,"2018":522,"2019":523,"2020":524,"2021":368,"2022":229,"2023":39},0.38,0.32,0.37,[],"http:\u002F\u002Fjournal.ussh.vnu.edu.vn\u002Findex.php\u002Fvjossh","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F2b8d7b12-2d20-4777-be98-077f44f03c69\u002F0bd0751202944a4b4165b482e6e623e4.png",{"impactFactor":36,"impactFactorByYear":529,"i10Index":162,"i10IndexLast5Year":115,"totalPublication":530,"totalPublicationByYear":531,"totalCitation":537,"totalCitationByYear":538,"totalCitationPerPublication":343,"totalCitationPerPublicationByYear":540,"hindexLast5Year":135,"hindex":135},{"2016":341,"2017":39,"2018":229,"2019":38,"2020":110,"2021":231,"2022":231,"2023":341,"2024":39},764,{"2015":255,"2016":245,"2017":532,"2018":259,"2019":533,"2020":534,"2021":535,"2022":536,"2023":534,"2024":254,"2025":50},111,106,68,92,89,265,{"2015":539,"2016":241,"2017":168,"2018":51,"2019":349,"2020":260,"2021":244,"2022":298,"2023":114},46,{"2015":541,"2016":523,"2017":524,"2018":290,"2019":542,"2020":522,"2021":523,"2022":57,"2023":39},1.48,0.63,{"id":544,"createTime":545,"updateTime":546,"relativeEntities":547,"slug":548,"properties":549,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":558,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":50,"subjectFields":559,"manageAffiliations":560,"indexDatabases":561,"url":562,"thumbnailPath":563,"statistic":564,"gsStatistic":26,"type":26,"analyzePriority":26},"6ec01bd0-15c0-469a-86ac-41339076ae0a","2023-08-10T07:08:33.153+00:00","2026-01-31T21:19:06.362+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Da-li%E1%BB%85u-h%E1%BB%8Dc-Vi%E1%BB%87t-Nam",{"country":550,"issn":551,"introduce":553,"title":555},{"VOID":15},{"VOID":552},"18594824",{"VI":554},"{\"ops\":[{\"insert\":\"Tạp chí “Da liễu học Việt Nam” (Tiếng Anh: Vietnamese Journal of Dermatology and Venereology) thuộc Hội Da liễu Việt Nam, xuất bản 4 số mỗi năm bằng tiếng Việt hoặc tiếng Anh.\\nTạp chí Da liễu học Việt Nam hoạt động với mục đích, tôn chỉ là phổ biến, trao đổi thông tin trong lĩnh vực chuyên ngành da liễu; đăng tải các công trình nghiên cứu khoa học; chuyển giao công nghệ - kinh tế và khoa học kỹ thuật liên quan đến lĩnh vực da liễu.\\nPhạm vi của tạp chí là tất cả các bài báo khoa học, bài tổng quan, giới thiệu ca lâm sàng, … có liên quan tới chuyên ngành da liễu trong và ngoài nước. Tạp chí công bố các công trình nghiên cứu liên quan đến mô hình bệnh tật, các phương pháp chẩn đoán, điều trị, dự phòng và phục hồi chức năng các bệnh thuộc chuyên ngành da liễu. Ngoài ra, tạp chí còn đăng tải các bài tổng quan, cập nhật thông tin, kiến thức, hướng dẫn chẩn đoán, điều trị trong chuyên ngành da liễu trong nước và quốc tế; đăng tải các bài ca lâm sàng đặc biệt trong chuyên ngành da liễu.\\nTạp chí Da liễu học Việt Nam được biết tới là một tạp chí chuyên ngành có uy tín trong lĩnh vực da liễu. Các bài báo về nghiên cứu khoa học đăng trong Tạp chí được bình duyệt một cách nghiêm ngặt bởi ít nhất 2 chuyên gia. Hội đồng biên tập tạp chí bao gồm các nhà khoa học có uy tín (Giáo sư, Phó Giáo sư, Tiến sĩ, Bác sĩ…) trong chuyên ngành da liễu nhằm đảm bảo chất lượng và tính khách quan, khoa học cho các bài viết đăng trên Tạp chí.\\n\"}]}",{"EN":556,"VI":557},"Vietnamese Journal of Dermatology and Venereology","Tạp chí Da liễu học Việt Nam","Admin Import",[],[],[],"https:\u002F\u002Fvjdv.vn\u002Findex.php\u002Fvjdv","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F6ec01bd0-15c0-469a-86ac-41339076ae0a\u002F3cbc81720e58429dc7b1c4d7ab1935ca.jpg",{"impactFactor":36,"impactFactorByYear":565,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":566,"totalPublicationByYear":567,"totalCitation":116,"totalCitationByYear":570,"totalCitationPerPublication":109,"totalCitationPerPublicationByYear":571,"hindexLast5Year":115,"hindex":115},{"2023":38,"2024":230},182,{"2022":568,"2023":45,"2024":569},69,56,{"2022":52,"2023":115},{"2022":40,"2023":229},{"id":573,"createTime":574,"updateTime":575,"relativeEntities":576,"slug":577,"properties":578,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":587,"translateLanguages":26,"viewCount":283,"subjectFields":588,"manageAffiliations":589,"indexDatabases":647,"url":648,"thumbnailPath":649,"statistic":650,"gsStatistic":26,"type":26,"analyzePriority":26},"19221551-7519-47ff-a892-331d1139c64b","2023-09-12T07:03:05.744+00:00","2026-01-24T20:54:40.144+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-S%E1%BB%A9c-kho%E1%BA%BB-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":579,"issn":580,"introduce":582,"title":584},{"VOID":15},{"VOID":581},"27349446",{"EN":583},"{\"ops\":[{\"attributes\":{\"bold\":true},\"insert\":\"1. History\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Science and Technology Development Journal\"},{\"insert\":\" (STDJ) (ISSN 2734-9446), Vietnam National University - Ho Chi Minh City (VNU-HCM) was established in 1997. And the first issue was published in January 1998 with ISSN 1859-0128. Since then, STDJ has become the most important scientific forum of scientists from VNU-HCM as well as other universities. The magazine has undergone 20 years of development and has become a bridge for scientific exchanges, as well as enriching reference materials for the faculty, doctoral students, students of VNU-HCM in particular and other universities, institutes...\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Science and Technology Development Journal - Health Sciences (STDJ-HS) is a subjournal of Science and Technology Development Journal since 2020.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\" \"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"2. Focus and Scope\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Publishing articles with contents on healthcare, research projects in the field of health, advanced directions in health education and management. Therefore, STDJ-HS will accept articles from doctors, administrators, teachers, researchers, graduate students and fellows. The authors will be responsible for the accuracy of the data, opinions, opinions and material cited in the article.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Facilitating the exchange of scientific and technological information and act as a bridge between theory and practice in the community of educators, scientists, managers, policy makers and enterprises in and out of the country.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":585,"VI":586},"VNUHCM JOURNAL OF HEALTH SCIENCES","Tạp chí Khoa học Sức khoẻ Đại học Quốc gia Thành phố Hồ Chí Minh",[101,102],[],[590],{"id":591,"createTime":592,"updateTime":593,"relativeEntities":594,"slug":595,"properties":596,"entityType":98,"verifyStatus":25,"verifyTime":606,"verifyNote":26,"syncStatus":28,"languages":607,"translateLanguages":26,"viewCount":608,"url":609,"parentIds":610,"statistic":611},"fc4c2560-868c-4677-acb1-8686bef88727","2023-06-26T04:48:23.774+00:00","2026-06-19T01:46:17.248+00:00",[],"%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":597,"title":598,"abbreviation":601,"address":603},{"VOID":15},{"EN":599,"VI":600},"Vietnam National University Ho Chi Minh City","Đại học Quốc gia Thành phố Hồ Chí Minh",{"VOID":602},"VNUHCM",{"VI":604,"EN":605},"khu phố 6, Phường Linh Trung, Thành phố Thủ Đức, Thành phố Hồ Chí Minh, Việt Nam","Quarter 6, Linh Trung Ward, Thu Duc City, Ho Chi Minh City, Vietnam","2023-08-16T14:13:07.134+00:00",[101,102],45,"https:\u002F\u002Fvnuhcm.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":612,"i10Index":285,"i10IndexLast5Year":51,"totalPublication":613,"totalPublicationByYear":614,"totalCitation":624,"totalCitationByYear":625,"totalCitationPerPublication":634,"totalCitationPerPublicationByYear":635,"hindexLast5Year":124,"hindex":124},{"2014":36,"2015":38,"2016":109,"2017":39,"2018":229,"2019":38,"2020":110,"2021":171,"2022":110,"2023":110,"2024":171,"2025":229},3708,{"2005":115,"2006":115,"2007":115,"2008":135,"2009":111,"2010":53,"2011":52,"2012":568,"2013":615,"2014":351,"2015":616,"2016":469,"2017":617,"2018":127,"2019":618,"2020":619,"2021":620,"2022":621,"2023":622,"2024":623,"2025":159,"2026":50},164,266,177,226,603,931,314,246,74,2399,{"2006":115,"2008":50,"2010":162,"2011":242,"2012":222,"2013":43,"2014":626,"2015":627,"2016":628,"2017":629,"2018":258,"2019":630,"2020":631,"2021":632,"2022":633,"2023":353,"2024":115},250,124,157,162,152,385,559,128,0.65,{"2006":115,"2008":636,"2010":637,"2011":638,"2012":639,"2013":522,"2014":640,"2015":641,"2016":642,"2017":643,"2018":644,"2019":642,"2020":645,"2021":292,"2022":646,"2023":522,"2024":38},1.33,0.45,2.22,0.39,1.35,0.47,0.67,0.92,0.73,0.64,0.41,[],"http:\u002F\u002Fstdjhs.scienceandtechnology.com.vn\u002Findex.php\u002Fstdjhs","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F19221551-7519-47ff-a892-331d1139c64b\u002F2e10768b7d1e380c36a25ed0c714dd7e.png",{"impactFactor":36,"impactFactorByYear":651,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":652,"totalPublicationByYear":653,"totalCitation":516,"totalCitationByYear":654,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":655,"hindexLast5Year":59,"hindex":59},{"2022":57,"2023":108,"2024":39},79,{"2020":116,"2021":240,"2022":239,"2023":52,"2024":162,"2025":162},{"2020":59,"2021":51,"2022":59},{"2020":443,"2021":387,"2022":54},{"code":657,"data":658,"meta":26},"SUCCESS",{"id":659,"createTime":660,"updateTime":660,"relativeEntities":661,"slug":662,"properties":663,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":668,"manageAffiliations":669,"indexDatabases":670,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},"83289c5a-0e1a-4089-90d0-8447ef02c8ba","2023-12-05T06:03:54.978+00:00",[],"EMC-Ginecolog%C3%ADa-Obstetricia",{"issn":664,"title":666},{"VOID":665},"1283081X",{"EN":667},"EMC - Ginecología-Obstetricia",[],[],[],{"meta":672,"data":674},{"total":673},"233",[675,773,805,874,935,981,1038,1191,1294,1396],{"id":676,"createTime":677,"updateTime":678,"relativeEntities":679,"slug":680,"properties":681,"entityType":688,"verifyStatus":25,"verifyTime":689,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":691,"fullTextUrl":26,"authors":692,"publicationType":747,"publisherRelationship":748,"citationCount":36,"citationInfo":762,"publishDate":764,"publishYear":765,"citationAnalyzeStatus":766,"lastCitationAnalyze":767,"indexDatabases":26,"openAccess":26,"references":768,"isForceReanalyzing":772},"2e0022d8-691d-47c1-805b-2646aae83a4e","2024-01-24T08:55:54.986+00:00","2026-06-10T12:40:31.574+00:00",[],"Tratamiento-de-la-f%C3%ADstula-rectovaginal-y-de-las-secuelas-obst%C3%A9tricas",{"title":682,"doi":684,"gsPaper":686},{"ES":683},"Tratamiento de la fístula rectovaginal y de las secuelas obstétricas",{"VOID":685},"10.1016\u002Fs1283-081x(20)43720-8",{"VOID":687},"[\"8941905162942479020\"]","PUBLICATION","2024-05-03T00:37:56.136+00:00","Auto Verify","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X20437208",[693,709,721,733],{"id":694,"sortIndex":59,"researcher":26,"roles":695,"affiliations":697,"properties":706},"39888c05-cf30-4eaf-ab45-faf3ce88e0b8",[696],"AUTHOR",[698],{"id":26,"sortIndex":36,"affiliation":699,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":702,"slug":26,"properties":703,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"d4d18b5e-933d-4c7a-8252-f956d23d19a2","2024-01-24T08:55:55.012+00:00",[],{"title":704},{"VI":705},"Service de chirurgie gynécologique, Hôpital Jeanne-de-Flandre, CHU de Lille, avenue Eugène-Avinée, 59037 Lille cedex, France",{"title":707},{"VI":708},"S. Delplanque",{"id":710,"sortIndex":114,"researcher":26,"roles":711,"affiliations":712,"properties":718},"a42857fa-931d-4443-b6a7-eeb4d3d287d4",[696],[713],{"id":26,"sortIndex":36,"affiliation":714,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":715,"slug":26,"properties":716,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":717},{"VI":705},{"title":719},{"VI":720},"E. Declas",{"id":722,"sortIndex":115,"researcher":26,"roles":723,"affiliations":724,"properties":730},"cf770415-864d-4750-a611-abe739471221",[696],[725],{"id":26,"sortIndex":36,"affiliation":726,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":727,"slug":26,"properties":728,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":729},{"VI":705},{"title":731},{"VI":732},"G. Giraudet",{"id":734,"sortIndex":36,"researcher":26,"roles":735,"affiliations":736,"properties":742},"08fc2047-379d-421d-a1db-869f3b3936fd",[696],[737],{"id":26,"sortIndex":36,"affiliation":738,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":739,"slug":26,"properties":740,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":741},{"VI":705},{"title":743,"gsAuthor":745},{"VI":744},"M. Cosson",{"VOID":746},"[\"mra9H5MAAAAJ\"]","ARTICLE",{"url":691,"publisher":749,"properties":757},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":750,"slug":662,"properties":751,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":754,"manageAffiliations":755,"indexDatabases":756,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":752,"title":753},{"VOID":665},{"EN":667},[],[],[],{"volume":758,"pages":760},{"VOID":759},"56",{"VOID":761},"1-12",{"total":36,"publishYear":36,"statisticByYear":763},{},"2020-05-01",2020,"ERROR_IN_ANALYZE_CITATION","2026-06-10T12:40:31.573+00:00",[769],{"id":26,"text":770,"url":26,"identifiers":771},"Cosson, 2011",{},false,{"id":774,"createTime":775,"updateTime":776,"relativeEntities":777,"slug":778,"properties":779,"entityType":688,"verifyStatus":28,"verifyTime":776,"verifyNote":784,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":785,"fullTextUrl":26,"authors":786,"publicationType":747,"publisherRelationship":787,"citationCount":26,"citationInfo":26,"publishDate":803,"publishYear":804,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"f1ea3096-45fd-4619-a03a-153929dcf569","2023-12-09T22:02:25.273+00:00","2025-01-22T16:58:18.456+00:00",[],"Cirug%C3%ADa-de-los-tumores-epiteliales-malignos-del-ovario",{"title":780,"doi":782},{"EN":781},"Cirugía de los tumores epiteliales malignos del ovario",{"VOID":783},"10.1016\u002FS1283-081X(10)70778-5","Author title is blank","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X10707785",[],{"url":785,"publisher":788,"properties":796},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":789,"slug":662,"properties":790,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":793,"manageAffiliations":794,"indexDatabases":795,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":791,"title":792},{"VOID":665},{"EN":667},[],[],[],{"volume":797,"pages":799,"issue":801},{"VOID":798},"46",{"VOID":800},"1-16",{"VOID":802},"1","2010-01-01",2010,{"id":806,"createTime":807,"updateTime":808,"relativeEntities":809,"slug":810,"properties":811,"entityType":688,"verifyStatus":25,"verifyTime":808,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":115,"primaryUrl":817,"fullTextUrl":26,"authors":818,"publicationType":747,"publisherRelationship":858,"citationCount":26,"citationInfo":26,"publishDate":872,"publishYear":873,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"b54e748e-4493-4a03-a116-a214102ba6e1","2024-01-03T17:56:22.307+00:00","2025-01-24T03:28:32.126+00:00",[],"Menopausia",{"references":812,"title":814,"doi":815},{"VOID":813},"Netter, 1979, Menstruations post ménopausiques, 243\nAssociation Française pour l’Etude de la Ménopause (AFEM). La ménopause et son traitement. Brochure patiente; 2006. Disponible sur htpp:\u002F\u002Fwww.menopauseafem.com.\nGroupe d’Etude de la Ménopause et du Vieillissement. Fiche d’information aux patientes; 2013. Disponible sur htpp:\u002F\u002Fwww.gemvi.org.\nGillet JY. Ménopause. EMC (Elsevier Masson SAS, Paris), Gynécologie, 38-A-10, 1985.\nHemsell, 1974, Plasma precursors of oestrogen. correlation of the extent of conversion of plasma androstenedione to estrone with age, J Clin Endocrinol Metab, 38, 476, 10.1210\u002Fjcem-38-3-476\nGreendale, 1998, Symptom relief and side effects of postmenopausal hormones: results from the postmenopausal estrogen\u002Fprogestin interventions trial, Obstet Gynecol, 92, 982, 10.1016\u002FS0029-7844(98)00305-6\nGuthrie, 2005, Hot flushes during the menopause transition: a longitudinal study in Australian-born women, Menopause, 12, 460, 10.1097\u002F01.GME.0000155200.80687.BE\nMeriggliola, 2012, Menopause affects pain depending on pain type and characteristics, Menopause, 19, 517, 10.1097\u002Fgme.0b013e318240fe3d\nMagliano, 2010, Menopausal arthralgia: Fact or fiction, Maturitas, 67, 29, 10.1016\u002Fj.maturitas.2010.04.009\nRozenbaum H. Traitement Hormonal Substitutif. Ménopaurama AFEM 2003. Disponible sur htpp:\u002F\u002Fwww.menopauseafem.com.\nAFSSAPS. Mise au point actualisée sur le traitement hormonal de la ménopause (THM) 2006. Disponible sur http:\u002F\u002Fwww.afssaps.santé.fr.\nStrudee, 2011, Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health, Climacteric, 14, 302, 10.3109\u002F13697137.2011.570590\nGass, 2012, The 2012 hormone therapy position statement of The North American Menopause Society, Menopause, 19, 257, 10.1097\u002Fgme.0b013e31824b970a\nMaclennan, 2004, Oral oestrogen replacement therapy versus placebo for hot flushes, Cochrane Database Syst Rev, CD002978\nThe Writing Group For The Pepi Trial, 1996, Effects of hormone therapy on bone mineral density: results from the Postmenopausal estrogen\u002FProgestin Interventions trial, JAMA, 276, 1389, 10.1001\u002Fjama.1996.03540170033029\nHulleyu, 1998, Randomized trial of estrogen plus progestin for secondary prevention of coronary disease in postmenopausal women (HERS I), JAMA, 280, 605, 10.1001\u002Fjama.280.7.605\nWriting Group For The Women's Health Initiative Investigators, 2002, Risks and benefits of estrogen plus progestin in healthy post menopausal women, JAMA, 288, 321, 10.1001\u002Fjama.288.3.321\nNathorst-Böös, 1993, Is sexual life influenced by transdermal estrogen therapy? A double blind placebo controlled study in postmenopausal women, Acta Obstet Gynecol Scand, 72, 656, 10.3109\u002F00016349309021160\nLetombe B. Ménopause et sexualité. Résumé du congrès CNGOF, 2012.\nGem, 2011, Recommandations sur le traitement médicamenteux de l’ostéoporose post-ménopausique\nAnderson, 2004, Effects of conjugated equine estrogen in post menopausal women with hysterectomy: the Women's Health Initiative Randomized Trial, JAMA, 291, 1701, 10.1001\u002Fjama.291.14.1701\nCollaborative Group On Hormonal Factors In Breast Cancer, 1997, Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer, Lancet, 350, 1047, 10.1016\u002FS0140-6736(97)08233-0\nStefanick, 2006, Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy, JAMA, 295, 1647, 10.1001\u002Fjama.295.14.1647\nLacroix, 2011, WHI Investigators. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial, JAMA, 305, 1305, 10.1001\u002Fjama.2011.382\nChlebowski, 2010, Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women, JAMA, 304, 1684, 10.1001\u002Fjama.2010.1500\nMillion Women Study Collaborators, 2003, Breast cancer and hormone replacement therapy in the Million Women Study, Lancet, 362, 419, 10.1016\u002FS0140-6736(03)14065-2\nEspié, 2007, Breast cancer incidence and hormone replacement therapy: results from the MISSION study, prospective phase, Gynecol endocrinol, 23, 391, 10.1080\u002F09513590701382104\nFournier, 2008, Unequal risks for breast cancer associated with different hormone replacement therapies: results from E3N cohort study, Breast Cancer Res Treat, 107, 103, 10.1007\u002Fs10549-007-9523-x\nShapiro, 2011, Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies: Part 1. The Collaborative Reanalysis, J Fam Plann Reprod Health Care, 37, 103, 10.1136\u002Fjfprhc.2011.0078\nShapiro, 2011, Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies: part 2. The Women's Health Initiative: estrogen plus progestogen, J Fam Plann Reprod Health Care, 37, 165, 10.1136\u002Fjfprhc-2011-0090\nShapiro, 2011, Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies: part 3. The Women's Health Initiative: unopposed estrogen, J Fam Plann Reprod Health Care, 37, 225, 10.1136\u002Fjfprhc-2011-0091\nShapiro, 2012, Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies. Part 4: the Million Women Study, J Fam Plann Reprod Health Care, 38, 102, 10.1136\u002Fjfprhc-2011-100229\nPrentice, 2008, Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative Clinical Trial and Observational Study, Am J Epidemiol, 167, 1407, 10.1093\u002Faje\u002Fkwn090\nFournier, 2009, Estrogen-progestogen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?, J Clin Oncol, 27, 5138, 10.1200\u002FJCO.2008.21.6432\nBeral, 2011, Breast cancer risk in relation to the interval between menopause and starting hormone therapy, J Natl Cancer Inst, 103, 296, 10.1093\u002Fjnci\u002Fdjq527\nAFEM. Recommandation AFEM. février 2007. Disponible sur htpp:\u002F\u002Fwww.menopauseafem.com.\nGrady, 2002, Cardiovascular disease outcomes during 6,8 years of hormone therapy (HERS II), JAMA, 288, 49, 10.1001\u002Fjama.288.1.49\nPrentice, 2006, Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease, Am J Epidemiol, 163, 589, 10.1093\u002Faje\u002Fkwj079\nBath, 2005, Association between hormone replacement therapy and subsequent stroke: a meta-analysis, Br Med J, 330, 342, 10.1136\u002Fbmj.38331.655347.8F\nRossouw, 2007, Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause, JAMA, 297, 1465, 10.1001\u002Fjama.297.13.1465\nRenoux, 2010, Transdermel and oral hormone replacement therapy and the risk of stroke: a nested case-control study, Br Med J, 340, c2519, 10.1136\u002Fbmj.c2519\nMendelsohn, 2005, Molecular and cellular basis of cardiovascular gender differences, Science, 308, 1583, 10.1126\u002Fscience.1112062\nLobo, 2011, Different mechanisms for benefit and risk of coronary heart disease and stroke in early postmenopausal women: a hypothetical explanation, Menopause, 18, 237, 10.1097\u002Fgme.0b013e3181e9e538\nSimoncini, 2006, Effects of dydrogesterone and of its stable metabolite, 20-alpha-dihydrodydrogesterone, on nitric oxide synthesis in human endothelial cells, Fertil Steril, 86, 1235, 10.1016\u002Fj.fertnstert.2006.05.018\nMiller, 2008, Baseline characteristics of women enrolled in the Kronos early estrogen Prevention Study (KEEPS), Climateric, 11, 8\nJoann, 2013, The Kronos Early Estrogen Prevention, Women's health, 9, 9, 10.2217\u002Fwhe.12.69\nKeeps results give insight into hormone therapy. http:\u002F\u002Fwww.menopause.org\u002Fannual-meetings\u002F2012-meeting\u002Fkeeps-report.\nde Villiers, 2013, Global consensus statement on menopausal hormone therapy, Climateric, 16, 203, 10.3109\u002F13697137.2013.771520\nKanaya, 2003, Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen\u002Fprogestin Replacement Study. A randomized, double-blind, placebo controlled trial, Ann Intern Med, 138, 1, 10.7326\u002F0003-4819-138-1-200301070-00005\nMargolis, 2004, Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial, Diabetologia, 47, 1175, 10.1007\u002Fs00125-004-1448-x\nDe Lauzon-Guillain, 2009, Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Générale de l’Education Nationale (E3N) cohort, Diabetologia, 52, 2092, 10.1007\u002Fs00125-009-1456-y\nRylance, 1985, Natural progesterone and antihypertensive action, Br Med J, 290, 13, 10.1136\u002Fbmj.290.6461.13\nLee, 2011, Effects of hormone therapy on ambulatory blood pressure in postmenopausal Korean women, Climacteric, 14, 92, 10.3109\u002F13697137.2010.491924\nScarabin, 2003, Differential association of oral and transdermal œstrogen-replacement therapy with venous thromboembolism risk, Lancet, 362, 428, 10.1016\u002FS0140-6736(03)14066-4\nCanonico, 2007, Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestens, Circulation, 115, 840, 10.1161\u002FCIRCULATIONAHA.106.642280\nSanten, 2010, Postmenopausal hormone therapy: an Endocrine Society scientific statement, J Clin Endocrinol Metab, 95, 1, 10.1210\u002Fjc.2009-2509\nHerrington, 2002, Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease, Arterioscler Thromb Vasc Biol, 22, 1012, 10.1161\u002F01.ATV.0000018301.91721.94\nCanonico, 2006, Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration, J Thromb Haemost, 4, 1259, 10.1111\u002Fj.1538-7836.2006.01933.x\nOlié, 2011, Hormone therapy and recurrence of venous thromboembolism among postmenopausal women, Menopause, 18, 488, 10.1097\u002Fgme.0b013e3181f9f7c3\nGrady, 1995, Hormone replacement therapy and endometrial cancer risk: a meta-analysis, Obstet Gynecol, 85, 304, 10.1016\u002F0029-7844(94)00383-O\nBeresford, 1997, Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women, Lancet, 349, 458, 10.1016\u002FS0140-6736(96)07365-5\nAllen, 2010, Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation into Cancer and Nutrition, Am J Epidemiol, 172, 1394, 10.1093\u002Faje\u002Fkwq300\nSomboonporn, 2011, Effects of the levonorgestrel-releasing intrauterine system plus estrogen therapy in perimenopausal and postmenopausal women: systematic review and meta-analysis, Menopause, 18, 1060, 10.1097\u002Fgme.0b013e31821606c5\nLacey, 2006, Menopausal hormone therapy and ovarian cancer risk in the National institutes of Health-AARP Diet and Health Study Cohort, J Natl Cancer Inst, 98, 1397, 10.1093\u002Fjnci\u002Fdjj375\nLacey, 2002, Menopausal hormone replacement therapy and risk of ovarian cancer, JAMA, 288, 334, 10.1001\u002Fjama.288.3.334\nGreen, 2012, Menopausal hormone therapy and risk of gastrointestinal cancer: nested case control study within a prospective cohort, and meta-analysis, Int J Cancer, 30, 2387, 10.1002\u002Fijc.26236\nLin, 2012, The effect of estrogen vs. combined estrogen-progestogen therapy on the risk of colorectal cancer, Int J Cancer, 130, 419430, 10.1002\u002Fijc.26026\nMorois, 2012, Menopausal hormone therapy and risks of colorectal adenomas and cancers in the French E3N prospective cohort: true associations or bias?, Eur J Epidemiol, 27, 439, 10.1007\u002Fs10654-012-9694-6\nHogervorste, 2000, The nature of the effect of female gonadal hormone replacement therapy on cognitive function in postmenopausal women: a meta-analysis, Neuroscience, 101, 485, 10.1016\u002FS0306-4522(00)00410-3\nLeblanc, 2002, Hormone replacement therapy and cognition, Syst Evid Rev\nRoberts, 2006, Postmenopausal estrogen therapy, et alzheimer disease: overall negative findings, Alzheimer Dis Assoc Disord, 20, 141, 10.1097\u002F00002093-200607000-00004\nHenderson, 2006, Estrogen-containing hormone therapy, et alzheimer's disease risk: understanding discrepant inferences from observational and experimental research, Neuroscience, 138, 1031, 10.1016\u002Fj.neuroscience.2005.06.017\nTamborini, 2012, Ménopause et THM : ou en est-on dix ans après la WHI, Real Gynecol Obstet\nHammar, 1998, A double-blind, randomised trial comparing the effect of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms, Br J Obstet gynecol, 105, 904, 10.1111\u002Fj.1471-0528.1998.tb10237.x\nRoux, 2000, Tibolone and cc E2\u002FNETA are effective in the prevention of postmenopausal bone loss, Maturitas, 35\nSismondi, 2011, Effects of tibolone on climacteric symptoms and quality of life in breast cancer patients-data from LIBERATE trial, Maturitas, 70, 365, 10.1016\u002Fj.maturitas.2011.09.003\nHitchcock, 2012, Oral micronized progesterone for vasomotor symptoms: a placebo-controlled randomized trial in healthy postmenopausal women, Menopause, 19, 886, 10.1097\u002Fgme.0b013e318247f07a\nNelson, 2006, Nonhormonal therapies for menopausal hot flushes. Systematic review and meta-analysis, JAMA, 295, 2057, 10.1001\u002Fjama.295.17.2057\nCarpenter, 2012, Effect of escitalopram on hot flash interference: a randomized, controlled trial, Fertil Steril, 97, 1399, 10.1016\u002Fj.fertnstert.2012.03.001\nRoueche, 1991, Abufene 400 mg et bouffées de chaleur. Etude en double aveugle versus placebo, Rev Prat Med Gen, 5, 2385\nTaylor, 2012, Complementary and alternative medicine preparations used to treat symptoms of menopause, Menopausal Med, 22\nBolanos, 2010, Soy isoflavones versus placebo in the treatment of climacteric vasomotor symptoms: systematic review and meta-analysis, Menopause, 17, 660, 10.1097\u002Fgme.0b013e3181cb4fb5\nLethaby, 2007, Phytoestrogens for vasomotor menopausal symptoms, Cochrane Database Syst Rev, CD001395\nHirata, 1997, Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial, Fertil Steril, 68, 981, 10.1016\u002FS0015-0282(97)00397-X\nWiklund, 1999, Effects of a standardized ginseng extract on quality of life and physiological parameters in symptomatic postmenopausal women: a double-blind, placebo-controlled trial. Swedish Alternative Medicine Group, Int J Clin Pharmacol Res, 19, 89\nBordet, 2008, Treating hot flushes in menopausal women with homeopathic treatment - results of an observational study, Homeopathy, 97, 10, 10.1016\u002Fj.homp.2007.11.005\nMartino, 2004, CORE Investigators. Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene, J Natl Cancer Inst, 96, 1751, 10.1093\u002Fjnci\u002Fdjh319\nEttinger, 1999, Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene. Results from a 3-year randomized clinical trial, JAMA, 282, 637, 10.1001\u002Fjama.282.7.637\nTremollieres, 2001, Les alternatives du traitement hormonal dans la prévention de l’ostéoporose : les bisphosphonates, Gynecol Obstet Fertil, 29, 846, 10.1016\u002FS1297-9589(01)00230-2\nGroup, 2008, Annual zoledronic acid for osteoporosis, Drug Ther Bull, 46, 93\nHAS. Avis de la Comission de transparence sur le Protelos. Septembre 2011. Disponible sur http:\u002F\u002F.has-sante.fr.\nHuang, 2010, An intensive. behavioural weight loss intervention and hot flushes in women, Arch Intern Med, 27, 170\nHAS. Avis de la Commission de Transparence sur le Denosumab. Décembre 2011. Disponible sur htpp:\u002F\u002Fwww.has-sante.fr.\nCummings, 2009, Denosumab for prevention of fractures in postmenopausal women with osteoporosis. FREEDOM Trial, N Engl J Med, 361, 756, 10.1056\u002FNEJMoa0809493",{"ES":810},{"VOID":816},"10.1016\u002Fs1283-081x(15)72832-8","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X15728328",[819,834,846],{"id":820,"sortIndex":36,"researcher":26,"roles":821,"affiliations":822,"properties":831},"e58375c9-cdee-4c69-97aa-cea12cbfdfe9",[696],[823],{"id":26,"sortIndex":36,"affiliation":824,"properties":26},{"id":825,"createTime":826,"updateTime":826,"relativeEntities":827,"slug":26,"properties":828,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"7196bfd0-7a03-45f7-9e5d-f49c41e90821","2024-01-03T17:56:22.313+00:00",[],{"title":829},{"VI":830},"Service de Gynécologie et Médecine du couple, Hôpital Jeanne-de-Flandre, CHRU de Lille, avenue Eugène-Avinée, 59037 Lille cedex, France",{"title":832},{"VI":833},"H. Baffet",{"id":835,"sortIndex":115,"researcher":26,"roles":836,"affiliations":837,"properties":843},"e9005ce9-a9bb-4cfb-9a29-004183354a74",[696],[838],{"id":26,"sortIndex":36,"affiliation":839,"properties":26},{"id":825,"createTime":826,"updateTime":826,"relativeEntities":840,"slug":26,"properties":841,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":842},{"VI":830},{"title":844},{"VI":845},"G. Robin",{"id":847,"sortIndex":114,"researcher":26,"roles":848,"affiliations":849,"properties":855},"74a5970d-a5d8-40d0-810b-6bee9d1a6ad7",[696],[850],{"id":26,"sortIndex":36,"affiliation":851,"properties":26},{"id":825,"createTime":826,"updateTime":826,"relativeEntities":852,"slug":26,"properties":853,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":854},{"VI":830},{"title":856},{"VI":857},"B. Letombe",{"url":817,"publisher":859,"properties":867},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":860,"slug":662,"properties":861,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":864,"manageAffiliations":865,"indexDatabases":866,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":862,"title":863},{"VOID":665},{"EN":667},[],[],[],{"volume":868,"pages":870},{"VOID":869},"51",{"VOID":871},"1-18","2015-09-01",2015,{"id":875,"createTime":876,"updateTime":877,"relativeEntities":878,"slug":879,"properties":880,"entityType":688,"verifyStatus":25,"verifyTime":877,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":887,"fullTextUrl":26,"authors":888,"publicationType":747,"publisherRelationship":919,"citationCount":26,"citationInfo":26,"publishDate":933,"publishYear":934,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"4c7e5ab1-3b75-42b6-a1e4-f0e78bc5a2d4","2023-12-11T19:04:18.521+00:00","2025-01-25T13:48:03.130+00:00",[],"Estrategias-de-diagn%C3%B3stico-prenatal-y-tratamiento-de-los-trastornos-asociados-al-embarazo-m%C3%BAltiple",{"references":881,"title":883,"doi":885},{"VOID":882},"Dommergues, 2002, Prenatal diagnosis for multiple pregnancies, Curr. Opin. Obstet. Gynecol., 14, 169, 10.1097\u002F00001703-200204000-00011\nEvans, 2001, Improvement in outcomes of multifetal pregnancy reduction with increased experience, Am. J. Obstet. Gynecol., 184, 97, 10.1067\u002Fmob.2001.108074\nLipitz, 2001, A comparative study of multifetal pregnancy reduction from triplets to twins in the first versus early second trimesters after detailed fetal screening, Ultrasound Obstet. Gynecol., 18, 35, 10.1046\u002Fj.1469-0705.2001.00431.x\nDe Catte, 2002, Obstetric outcome after fetal reduction to singleton pregnancy, Prenat. Diagn., 22, 206, 10.1002\u002Fpd.285\nDe Catte, 2002, Monochorionic high-order multiple pregnancies and multifetal pregnancy reduction, Obstet. Gynecol., 100, 561, 10.1016\u002FS0029-7844(02)02075-6\nDommergues, 1999, Multifetal pregnancy reduction and selective termination, 879\nDumez, 1991, First-trimester prenatal diagnosis in quintuplets: a practical approach using step-by-step embryo reduction, Prenat. Diagn., 11, 737, 10.1002\u002Fpd.1970110912\nMeyers, 1997, Aneuploidy in twin gestations: when is maternal age advanced?, Obstet. Gynecol., 89, 248, 10.1016\u002FS0029-7844(96)00424-3\nSpencer, 1994, Down's syndrome screening in multiple pregnancies using alpha-foetoprotein and free beta hCG, Prenat. Diagn., 18, 537, 10.1002\u002Fpd.1970140705\nWald, 1994, Maternal serum free beta-hCG levels in twin pregnancies: implications for screening for Down's syndrome, Prenat. Diagn., 14, 319, 10.1002\u002Fpd.1970140415\nSpencer, 2001, Screening for trisomy 21 in twin pregnancies in the first trimester: does chorionicity impact on maternal serum free beta hCG or PAPP-A levels, Prenat. Diagn., 21, 715, 10.1002\u002Fpd.152\nRaty, 2000, Maternal midtrimester serum AFP and free beta-hCG levels in in vitro fertilization twin pregnancies, Prenat. Diagn., 20, 221, 10.1002\u002F(SICI)1097-0223(200003)20:3\u003C221::AID-PD787>3.0.CO;2-S\nSebire, 1996, Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10–14 weeks of gestation, Br. J. Obstet. Gynaecol., 103, 999, 10.1111\u002Fj.1471-0528.1996.tb09550.x\nSpencer, 2000, Screening for trisomy 21 in twin pregnancies in the first trimester using free beta-hCG and PAPP-A, combined with fetal nuchal translucency thickness, Prenat. Diagn., 20, 91, 10.1002\u002F(SICI)1097-0223(200002)20:2\u003C91::AID-PD759>3.0.CO;2-X\nYukobowich, 2001, Risk of fetal loss in twin pregnancies undergoing second trimester amniocentesis, Obstet. Gynecol., 98, 231, 10.1016\u002FS0029-7844(01)01416-8\nWapner, 1993, Prenatal diagnosis in twin gestations: a comparison between second-trimester amniocentesis and first-trimester chorionic villus sampling, Obstet. Gynecol., 82, 49\nDe Catte, 2000, Outcome of twin gestations after first trimester chorionic villus sampling, Obstet. Gynecol., 96, 714, 10.1016\u002FS0029-7844(00)00991-1\nBrambati, 2001, Ultrasound outcome of first-trimester chorionic villus sampling for genetic investigation in multiple pregnancy, Obstet. Gynecol., 17, 209\nSepulveda, 2000, Severe polyhydramnios in twin reversed arterial perfusion sequence: successful management with intrafetal alcohol ablation of acardiac twin and amniodrainage, Ultrasound Obstet. Gynecol., 16, 260, 10.1046\u002Fj.1469-0705.2000.00212.x\nTongsong, 2002, Intrauterine treatment for an acardiac twin with alcohol injection into the umbilical artery, J. Obstet. Gynaecol. Res., 28, 76, 10.1046\u002Fj.1341-8076.2002.00017.x\nDeprest, 2000, Bipolar coagulation of the umbilical cord in complicated monochorionic twin pregnancy, Am. J. Obstet. Gynecol., 182, 340, 10.1016\u002FS0002-9378(00)70221-3\nHolmes, 2001, Monopolar thermocoagulation in acardiac twinning, Br. J. Obstet. Gynaecol., 108, 1000, 10.1016\u002FS0306-5456(01)00234-0\nTsao, 2002, Selective reduction of acardiac twin by radiofrequency ablation, Am. J. Obstet. Gynecol., 187, 635, 10.1067\u002Fmob.2002.125242\nDommergues, 1995, Twin-to-twin transfusion syndrome: selective feticide by embolization of the hydropic fetus, Fetal Diagn. Ther., 10, 26, 10.1159\u002F000264188\nDeprest, 1998, Experience with fetoscopic cord ligation, Eur. J. Obstet. Gynecol. Reprod. Biol., 81, 157, 10.1016\u002FS0301-2115(98)00181-X\nNicolini, 2001, Complicated monochorionic twin pregnancies: experience with bipolar cord coagulation, Am. J. Obstet. Gynecol., 185, 703, 10.1067\u002Fmob.2001.117190\nLopoo, 2000, Cord ultrasonic transection procedure for selective termination of a monochorionic twin, Fetal. Diagn. Ther., 15, 177, 10.1159\u002F000021001\nEvans, 1999, Selective termination for structural, chromosomal, and mendelian anomalies: international experience, Am. J. Obstet. Gynecol., 181, 893, 10.1016\u002FS0002-9378(99)70321-2\nVan Gemert, 2000, Classification of discordant fetal growth may contribute to risk stratification in monochorionic twin pregnancies, Ultrasound. Obstet. Gynecol., 16, 237, 10.1046\u002Fj.1469-0705.2000.00226.x\nQuintero, 2001, Selective photocoagulation of communicating vessels in the treatment of monochorionic twins with selective growth retardation, Am. J. Obstet. Gynecol., 185, 689, 10.1067\u002Fmob.2001.116724\nSmith, 2001, A prospective study of growth velocity in twin pregnancy, Ultrasound. Obstet. Gynecol., 18, 485, 10.1046\u002Fj.0960-7692.2001.00519.x\nSebire, 2000, Early prediction of severe twin-to-twin transfusion syndrome, Hum. Reprod., 15, 2008, 10.1093\u002Fhumrep\u002F15.9.2008\nSebire, 2001, Twin-to-twin transfusion syndrome results from dynamic asymmetrical reduction in placental anastomoses: a hypothesis, Placenta, 22, 383, 10.1053\u002Fplac.2001.0631\nBajoria, 2001, Placental regulation of insulin-like growth factor axis in monochorionic twins with chronic twin-twin transfusion syndrome, J. Clin. Endocrinol. Metab., 86, 3150, 10.1210\u002Fjc.86.7.3150\nSooranna, 2001, Discordant fetal leptin levels in monochorionic twins with chronic midtrimester twin-twin transfusion syndrome, Placenta, 22, 392, 10.1053\u002Fplac.2001.0654\nBajoria, 2000, Discordant amino acid profiles in monochorionic twins with twin-twin transfusion syndrome, Pediatr. Res., 48, 821, 10.1203\u002F00006450-200012000-00020\nBajoria, 2001, Iron metabolism in monochorionic twin pregnancies in relation to twin– twin transfusion syndrome, Hum. Reprod., 16, 567, 10.1093\u002Fhumrep\u002F16.3.567\nBajoria, 2001, Erythropoietin in monochorionic twin pregnancies in relation to twin– twin transfusion syndrome, Hum. Reprod., 16, 574, 10.1093\u002Fhumrep\u002F16.3.574\nUmur, 2001, Amniotic fluid and hemodynamic model in monochorionic twin pregnancies and twin-twin transfusion syndrome, Am. J. Physiol. Regul. Integr. Comp. Physiol., 280, R1499, 10.1152\u002Fajpregu.2001.280.5.R1499\nMahieu-Caputo, 2000, Twin-to-twin transfusion syndrome. Role of the fetal renin-angiotensin system, Am. J. Pathol., 156, 629, 10.1016\u002FS0002-9440(10)64767-0\nKilby, 2001, Renin gene expression in fetal kidneys of pregnancies complicated by twin-twin transfusion syndrome, Pediatr. Dev. Pathol., 4, 175, 10.1007\u002Fs100240010124\nMahieu-Caputo, 2001, Pathogenesis of twin-twin transfusion syndrome: the renin-angiotensin system hypothesis, Fetal. Diagn. Ther., 16, 241, 10.1159\u002F000053919\nCheung, 2000, Fetal origins of reduced arterial distensibility in the donor twin in twin-twin transfusion syndrome, Lancet, 355, 1157, 10.1016\u002FS0140-6736(00)02068-7\nVille, 1998, Endoscopic laser coagulation in the management of severe twin-to-twin transfusion syndrome, Br. J. Obstet. Gynaecol., 105, 446, 10.1111\u002Fj.1471-0528.1998.tb10132.x\nZikulnig, 1999, Prognostic factors in severe twin-twin transfusion syndrome treated by endoscopic laser surgery, Ultrasound Obstet. Gynecol., 14, 380, 10.1046\u002Fj.1469-0705.1999.14060380.x\nHecher, 2000, Endoscopic laser coagulation of placental anastomoses in 200 pregnancies with severe mid-trimester twin-to-twin transfusion syndrome, Eur. J. Obstet. Gynecol. Reprod. Biol., 92, 135, 10.1016\u002FS0301-2115(00)00437-1\nSmith, 2001, A prospective longitudinal study of growth velocity in twin pregnancy, Ultrasound Obstet. Gynecol., 18, 485, 10.1046\u002Fj.0960-7692.2001.00519.x\nMari, 2000, Long-term outcome in twin-twin transfusion syndrome treated with serial aggressive amnioreduction, Am. J. Obstet. Gynecol., 183, 211, 10.1016\u002FS0002-9378(00)66819-9\nJoa, 2001, Twin-to-twin transfusion syndrome: a review of 27 cases and the relationship between gestational age at diagnosis and serial amniocentesis on outcome, Obstet. Gynecol., 97, S46\nCincotta, 2000, Long-term outcome of twin-twin transfusion syndrome, Arch. Dis. Child., 83, F171, 10.1136\u002Ffn.83.3.F171\nTaylor, 2000, Antenatal factors at diagnosis that predict outcomes in twin-twin transfusion syndrome, Am. J. Obstet. Gynecol., 183, 1023, 10.1067\u002Fmob.2000.107368\nHaverkamp, 2001, Neurodevelopmental risks in twin-to-twin transfusion syndrome: preliminary findings, Eur. J. Paediatr. Neurol., 5, 21, 10.1053\u002Fejpn.2001.0400\nHecher, 1999, Endoscopic laser surgery vs serial amniocenteses in the treatment of severe twin-twin transfusion syndrome, Am. J. Obstet. Gynecol., 180, 717, 10.1016\u002FS0002-9378(99)70278-4\nSenat, 2002, Management of single fetal death in twin-to-twin transfusion syndrome: a role for fetal blood sampling, Ultrasound. Obstet. Gynecol., 20, 360, 10.1046\u002Fj.1469-0705.2002.00815.x\nLarroche, 1990, Brain damage in monozygous twins, Biol. Neonate, 57, 261, 10.1159\u002F000243201\nHubinont, 2000, Twin-to-twin transfusion syndrome: treatment by amniodrainage and septostomy, Eur. J. Obstet. Gynecol. Reprod. Biol., 92, 141, 10.1016\u002FS0301-2115(00)00438-3\nQuintero, 2001, Selective laser photocoagulation of communicating vessels in severe twin-twin transfusion syndrome in women with an anterior placenta, Obstet. Gynecol., 97, 477, 10.1016\u002FS0029-7844(00)01172-8\nQuintero, 2000, Selective versus non-selective laser photocoagulation of placental vessels in twin-to-twin transfusion syndrome, Ultrasound Obstet. Gynecol., 16, 230, 10.1046\u002Fj.1469-0705.2000.00265.x\nThilaganathan, 2000, Sono-endoscopic delineation of the placental vascular equator prior to selective fetoscopic laser ablation in twin-to-twin transfusion syndrome, Ultrasound Obstet. Gynecol., 16, 226, 10.1046\u002Fj.1469-0705.2000.00272.x\nLuks, 2001, Preoperative planning with magnetic resonance imaging and computerized volume rendering in twin-to-twin transfusion syndrome, Am. J. Obstet. Gynecol., 185, 216, 10.1067\u002Fmob.2001.115111\nTaylor, 2000, Identification of arterio-venous anastomoses in vivo in monochorionic twin pregnancies: preliminary report, Ultrasound Obstet. Gynecol., 16, 218, 10.1046\u002Fj.1469-0705.2000.00227.x\nMachin, 2000, Doppler sonographic demonstration of arterio-venous anastomosis in monochorionic twin gestation, Ultrasound Obstet. Gynecol., 16, 214, 10.1046\u002Fj.1469-0705.2000.00231.x\nHartung, 2000, Amniotic fluid pressure in both cavities of twin-to-twin transfusion syndrome: a vote against septostomy, Fetal Diagn. Ther., 15, 79, 10.1159\u002F000020980",{"ES":884},"Estrategias de diagnóstico prenatal y tratamiento de los trastornos asociados al embarazo múltiple",{"VOID":886},"10.1016\u002Fs1283-081x(05)43394-9","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X05433949",[889,904],{"id":890,"sortIndex":36,"researcher":26,"roles":891,"affiliations":892,"properties":901},"e8f517da-d7bd-42af-8398-d8ff3884fc2e",[696],[893],{"id":26,"sortIndex":36,"affiliation":894,"properties":26},{"id":895,"createTime":896,"updateTime":896,"relativeEntities":897,"slug":26,"properties":898,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"2d1f2f73-1e2d-4fcd-8c9e-6438c05acf61","2023-12-26T11:16:04.126+00:00",[],{"title":899},{"VI":900},"Service de gynécologie–obstétrique, Groupe hospitalier Pitié-Salpêtrière, AP–HP et Université Paris VI, 47-83 boulevard de l'Hôpital, 75651 Paris cedex 13, France",{"title":902},{"VI":903},"M. Dommergues",{"id":905,"sortIndex":115,"researcher":26,"roles":906,"affiliations":907,"properties":916},"fddc93f9-b372-4811-b14c-4f2cbe1c9e1b",[696],[908],{"id":26,"sortIndex":36,"affiliation":909,"properties":26},{"id":910,"createTime":911,"updateTime":911,"relativeEntities":912,"slug":26,"properties":913,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"60ba3490-39ae-444f-8ca3-faa24066bf18","2023-12-26T11:16:04.142+00:00",[],{"title":914},{"VI":915},"Service de gynécologie–obstétrique, Hôpital Antoine Béclère, AP–HP et Université Paris XI, 92000 Clamart, France",{"title":917},{"VI":918},"O. Picone",{"url":887,"publisher":920,"properties":928},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":921,"slug":662,"properties":922,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":925,"manageAffiliations":926,"indexDatabases":927,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":923,"title":924},{"VOID":665},{"EN":667},[],[],[],{"volume":929,"pages":931},{"VOID":930},"41",{"VOID":932},"1-7","2005-01-01",2005,{"id":936,"createTime":937,"updateTime":938,"relativeEntities":939,"slug":940,"properties":941,"entityType":688,"verifyStatus":25,"verifyTime":938,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":948,"fullTextUrl":26,"authors":949,"publicationType":747,"publisherRelationship":965,"citationCount":26,"citationInfo":26,"publishDate":979,"publishYear":980,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"5b35e7c7-1234-4e37-9923-1c067ce27330","2023-12-13T16:17:00.040+00:00","2025-01-11T01:11:11.783+00:00",[],"Infecciones-genitales-altas",{"references":942,"title":944,"doi":946},{"VOID":943},"Ripa, 1990, Epidemiologic control of genital C. trachomatis infections, Scand. J. Infect. Dis., 69, 157\nEnquête nationale 1998 des centres d'assistance médicale à la procréation FIVNAT. Consultable sur: http:\u002F\u002Fperso.orange.fr\u002Ffivnat.fr\u002Findex.htm.\nSimms, 1999, The rate of diagnosis and demography of PID in general practice England and Wales, Int. J. STD AIDS, 10, 448, 10.1258\u002F0956462991914447\nKamwendo, 1996, Decreasing incidences of gonorrhea- and Chlamydia- associated acute pelvic inflammatory disease. A 25-year study from an urban area of central Sweden, Sex. Transm. Dis., 23, 384, 10.1097\u002F00007435-199609000-00007\nStray-Pedersen, 1996, Prévention des maladies sexuellement transmissibles. L'expérience norvégienne, Contracept. Fertil. Sex., 24, 213\nSorbye, 2005, Reduction of hospitalized women with pelvic inflammatory disease in Oslo over the past decade, Acta Obstet. Gynecol. Scand., 84, 290, 10.1080\u002Fj.0001-6349.2005.00509.x\nChacko, 2004, Chlamydia and gonorrhea screening in asymptomatic young women, J. Pediatr. Adolesc. Gynecol., 117, 169, 10.1016\u002Fj.jpag.2004.03.041\nRein, 2000, Direct medical cost of pelvic inflammatory disease and its sequelae: decreasing, but still substantial, Obstet. Gynecol., 95, 397\nYeh, 2003, A refine estimate of the average lifetime cost of pelvic inflammatory disease, Sex. Transm. Dis., 30, 369, 10.1097\u002F00007435-200305000-00001\nJonsson, 1997, The association between risk behaviour and reported history of sexually transmitted diseases, among young women: a population-based study, Int. J. STD AIDS, 8, 501, 10.1258\u002F0956462971920659\nGoulet V, Laurent E, de Barbeyrac B. Les infections à Clamydia trachomatis en France en 2003 : données du réseau Rénachla. Disponible sur htpp:\u002F\u002Fwww.invs.sante.fr.\nAgence Nationale d'Accréditation et d'Evaluation en Santé. Evaluation clinique et économique du dépistage des infections urogénitales à C. trachomatis en France. 2003. 95p. Disponible sur http:\u002F\u002Fwww.anaes.fr.\nPaavonen, 1999, C. trachomatis: impact on human reproduction, Hum. Reprod. Update, 5, 433, 10.1093\u002Fhumupd\u002F5.5.433\nBoecke, 2005, The risk of pelvic inflammatory disease associated with urogenital infection with Chlamydia trachomatis; literature review, Ned. Tijdschr. Geneeskd., 149, 850\nvan Valkengoed, 2004, Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes – implications for cost-effectiveness analyses, Int. J. Epidemiol., 33, 416, 10.1093\u002Fije\u002Fdyh029\nMorre, 2002, The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up, Int. J. STD AIDS, 13, 12, 10.1258\u002F095646202762226092\nHutchinson, 1979, Growth ant effect of Chlamydiae in human and bovine oviduct organ cultures, Br. J. Venereol., 55, 194\nWitkins, 1994, Proliferative response to conserved epitopes of the C. trachomatis and human 60-Kd heat-shock proteins by lymphocytes from women with salpingitis, Am. J. Obstet. Gynecol., 171, 455, 10.1016\u002F0002-9378(94)90282-8\nPatton, 1987, Distal tubal obstruction induced by repeated C. trachomatis salpingal infections in pigtail macaques, J. Infect. Dis., 155, 292, 10.1093\u002Finfdis\u002F155.6.1292\nHerida, 2006, Renago 2004 : gonococcies en hausse, progression importante de la résistance des souches à la ciprofloxacine, Bull. Epidémiol. Hebd., 1, 2\nHenry-Suchet, 1980, Études microbiologiques des prélèvements cœlioscopiques dans les annexites et les stérilités tubaires. Recherche de C. trachomatis et de mycoplasmes, J. Gynecol. Obstet. Biol. Reprod. (Paris), 9, 445\nDe Barbeyrac, 1993, Detection of M. pneumoniae and M. genitalium by polymerase chain reaction in clinical samples, Clin. Infect. Dis., 17, S83, 10.1093\u002Fclinids\u002F17.Supplement_1.S83\nSimms, 2003, Association between Mycoplasma genitalium, Clamydia trachomatis and pelvic inflammatory disease, J. Clin. Pathol., 56, 616, 10.1136\u002Fjcp.56.8.616\nJudlin, 2003, Mycoplasmes génitaux, Gynecol. Obstet. Fertil., 31, 954, 10.1016\u002Fj.gyobfe.2003.05.001\nRoss, 2006, Mycoplasma genitalium as a sexually transmitted infection: implication for screening, testing and treatment, Sex. Transm. Infect., 82, 269, 10.1136\u002Fsti.2005.017368\nHillier, 1993, Diagnostic microbiology of bacterial vaginosis, Am. J. Obstet. Gynecol., 169, 455, 10.1016\u002F0002-9378(93)90340-O\nKeane, 2000, The association of M. hominis, U. urealyticum and M. genitalium with bacterial vaginosis: Observations on heterosexual women and their male partners, Int. J. STD AIDS, 11, 356, 10.1258\u002F0956462001916056\nTaylor-Robinson, 1999, Genital Mycoplasma, 533\nNess, 2004, Bacterial vaginosis and risk of pelvic inflammatory disease, Obstet. Gynecol., 104, 761, 10.1097\u002F01.AOG.0000139512.37582.17\nQuentin, 2002, Prélèvements génitaux et examens sérologiques pour le diagnostic des infections génitales, 9\nMohllajee, 2006, Does insertion and use of intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review, Contraception, 73, 145, 10.1016\u002Fj.contraception.2005.08.007\nWalker, 1999, Anaerobes in pelvic inflammatory disease: implications for the Centers for Disease Control and Prevention's guidelines for treatment of sexually transmitted diseases, Clin. Infect. Dis., 28, S29, 10.1086\u002F514720\nCohen, 1998, Effect of HIV type 1 infection upon acute salpingitis: a laparoscopic study, J. Infect. Dis., 178, 1352, 10.1086\u002F314465\nIrwin, 2000, Influence of human deficiency virus infection on pelvic inflammatory disease, Obstet. Gynecol., 95, 525\nRoyal College of Obstetricians and Gynaecologists. Management of acute pelvic inflammatory disease. Guideline N. 32, May 2003, disponible sur: http:\u002F\u002Fwww.rcog.org.\n2006, Sexually Transmitted Diseases Treatment Guidelines, 2006, MMWR, 55, 1\nKahn, 1991, Diagnosing pelvic inflammatory disease. A comprehensive analysis and considerations for developing a new model, JAMA, 266, 2594, 10.1001\u002Fjama.1991.03470180094044\nSemchyshyn, 1979, Fitz-Hugh and Curtis syndrome, J. Reprod. Med., 22, 45\nPeter, 2004, Fitz-Hugh-Curtis syndrome: a diagnostic to consider in women with right upper quadrant pain, Cleve. Clin. J. Med., 71, 233, 10.3949\u002Fccjm.71.3.233\nJudlin, 1998, Endométrites à C. trachomatis, Contracept. Fertil. Sex., 26, 1\nLee, 1995, Diagnosis of Chlamydia trachomatis genitourinary infection in women with ligase chain reaction assay of urine, Lancet, 345, 213, 10.1016\u002FS0140-6736(95)90221-X\nWestrom, 1990, Acute pelvic inflammatory disease\nLedger, 1976, A new approach to patients with suspected anaerobic postpartum pelvic infections, Am. J. Obstet. Gynecol., 126, 1, 10.1016\u002F0002-9378(76)90455-5\nSarov, 1988\nSellors, 1988\nJudlin, 1993, Diagnostic et traitement des salpingites, 69\nBoardman, 1997, Endovaginal sonography for the diagnosis of upper genital tract infection, Obstet. Gynecol., 90, 54, 10.1016\u002FS0029-7844(97)00241-X\nTepper, 1998, Doppler flow characteristics in patients with pelvic inflammatory disease: responders vs non responders to therapy, J. Clin. Ultrasound, 26, 247, 10.1002\u002F(SICI)1097-0096(199806)26:5\u003C247::AID-JCU3>3.0.CO;2-C\nFeste, 1996, Use of optical catheters for diagnostic office laparoscopy, J. Reprod. Med., 41, 307\nBruhat, 1989, Adhérences, 73\nNess, 2005, Effectiveness of treatment strategies of some women with pelvic inflammatory disease: a randomized trial, Obstet. Gynecol., 106, 573, 10.1097\u002F01.AOG.0000175193.37531.6e\nCampo, 1999, Diagnostic accuracy of transvaginal hydrolaparoscopy in infertility, Fertil. Steril., 71, 1157\nTeisala, 1990, Laparoscopic diagnosis and treatment of acute pyosalpinx, J. Reprod. Med., 35, 19\nGabaude, 1987, Intérêt de l'échographie dans les infections pelviennes aiguës, Rev. Fr. Gynecol. Obstet., 82, 471\nKrivak, 2004, Tubo-ovarian abscess: diagnosis, medical and surgical management, Compr. Ther., 30, 93, 10.1007\u002Fs12019-004-0003-5\nKim, 2004, Unusual causes of tubo-ovarian abscess: CT and MR imaging findings, Radiographics, 24, 1575, 10.1148\u002Frg.246045016\nProtopapas, 2004, Tubo-ovarian abscesses in post-menopausal women: gynecological malignancy until proven otherwise?, Eur. J. Obstet. Gynecol. Reprod. Biol., 114, 203, 10.1016\u002Fj.ejogrb.2003.10.032\nVerit, 2005, Primary carcinoma of the Fallopian tube mimicking tubo-ovarian abscess, Eur. J. Obstet. Gynaecol. Oncol., 26, 225\nHuguier J, Scali P. Inflammations péri-utérines. Encycl Méd Chir (Elsevier SAS, Paris), Gynécologie, 470-B-20, 1965 : 20p.\nRaiga, 1996, Laparoscopic management of adnexal abcesses: consequences for fertility, Fertil. Steril., 66, 712, 10.1016\u002FS0015-0282(16)58623-3\nNyirjesy, 1994, Streptococcal toxic shock-like syndrome as an unusual complication of laparoscopic tubal ligation. A case report, J. Reprod. Med., 39, 649\nMonif, 1977, Group A Streptococcus as a cause of endometritis\u002Fsalpingitis\u002Fperitonitis in a nongravid female, Obstet. Gynecol., 50, 509\nWestrom, 1992\nNansel, 2006, The association of psychosocial stress and bacterial vaginosis in a longitudinal cohort, Am. J. Obstet. Gynecol., 194, 381, 10.1016\u002Fj.ajog.2005.07.047\nSweet, 1981, Etiology of acute salpingitis; influence of episode number and duration of symptoms, Obstet. Gynecol., 58, 62\nHenry-Suchet J, Dahan M, Tannous W. Salpingites aiguës non spécifiques. Conduite à tenir. Encycl Méd Chir (Elsevier SAS, Paris), Gynécologie, 470-A-10, 1995 : 18p.\nSafrin, 1992, Long-term sequelae of acute pelvic inflammatory disease: A retrospective cohort study, Am. J. Obstet. Gynecol., 166, 1300, 10.1016\u002FS0002-9378(11)90626-7\nSweet, 1995\nAbeille, 1983, La dystrophie ovarienne par en dehors, Contracept. Fertil. Sex., 11, 557\nBuckman, 1976, A unifying pathogenetic mechanism in the etiology of intraperitoneal adhesions, J. Surg. Res., 20, 1, 10.1016\u002F0022-4804(76)90075-5\nLeroy, 1988, Appréciation de l'évolutivité inflammatoire des séquelles de salpingites, J. Gynecol. Obstet. Biol. Reprod. (Paris), 17, 191\nMage, 1987\nStray-Pedersen, 1993\nAubriot, 1988, Les maladies sexuellement transmissibles et la stérilité féminine, Rev. Fr. Gynecol. Obstet., 83, 257\nHeinonen, 2003, Fecundity and morbidity following acute pelvic inflammatory disease treated with doxycyclin and métronidazole, Arch. Gynecol. Obstet., 268, 284, 10.1007\u002Fs00404-002-0376-6\nvan Valkengoed, 2001, Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infection in women by means of home obtained urine specimens, Sex. Transm. Infect., 77, 276, 10.1136\u002Fsti.77.4.276\nWatrelot, 1999, Evaluation of the performance of fertiloscopy in 160 consecutive infertile patients with no obvious pathology, Hum. Reprod., 14, 707, 10.1093\u002Fhumrep\u002F14.3.707\nKodaman, 2004, Evidence-based diagnosis and management of tubal factor infertility, Curr. Opin. Obstet. Gynecol., 16, 221, 10.1097\u002F00001703-200406000-00004\nDunbar-Jacob, 2004, Adherence to oral therapies in pelvic inflammatory disease, J. Womens Health, 13, 285, 10.1089\u002F154099904323016446\nElder, 1977, Pelvic tissue and serum concentrations of various antibiotics given as pre-operative medication, Br. J. Obstet. Gynaecol., 84, 887, 10.1111\u002Fj.1471-0528.1977.tb12516.x\nChimura, 1997\nJudlin, 1995, Étude comparative des associations ofloxacine + amoxicilline-acide clavulanique vs doxycycline + amoxicilline-acide clavulanique dans le traitement des infections génitales hautes à C. trachomatis, J. Gynecol. Obstet. Biol. Reprod. (Paris), 24, 253\nWalker, 1993, Pelvic inflammatory disease: Meta-analysis of antimicrobial regimen efficacy, J. Infect. Dis., 168, 969, 10.1093\u002Finfdis\u002F168.4.969\nKnudsen, 1998, Pharmacodynamics of penicillin are unaffected by bacterial growth phase of Streptococcus pneumoniaes in the mouse peritonitis model, J. Antimicrob. Chemother., 41, 451, 10.1093\u002Fjac\u002F41.4.451\nDe Mouy, 1998, E. coli et infections urinaires en pratique de ville : étude en fonction des antécédents d'hospitalisation et de traitement antibiotique, Bull. Épidémiol. Hebd., 28, 105\nWolff, 1994, Céphalosporines injectables, 74\nSweet, 1979, Cefoxitin: single-agent treatment of mixed aerobic-anaerobic pelvic infections, Obstet. Gynecol., 54, 193\nWitkins, 1994, Proliferative response to conserved epitopes of the C. trachomatis and human 60-kd heat shock proteins by lymphocytes from women with salpingitis, Am. J. Obstet. Gynecol., 171, 455, 10.1016\u002F0002-9378(94)90282-8\nPocidalo, 1985\nRoss, 2001, European guideline for the management of pelvic inflammatory disease and perihepatitis, Int. J. STD AIDS, 12, 84, 10.1258\u002F0956462011924001\nXia, 2002\nCho, 1992, Pharmacokinetic and clinical evaluation of levofloxacin in obstetrics and gynecology, Jpn. J. Antibiot., 45, 270\nMatsuda, 1992, Clinical study of levofloxacin on the infectious diseases in the field of obstetrics and gynecology, Chemotherapy, 40, 311\nCrémieux, 1989, Pénétration intracellulaire des antibiotiques, Lettre Infectiol., 20, 787\nPerronne, 1994, Macrolides, 153\nRidgway, 1996, Azithromycin in the management of Chlamydia trachomatis infections, Int. J. STD AIDS, 7, 5, 10.1258\u002F0956462961917221\n1994, 7e Conférence de Consensus en Thérapeutique Anti-infectieuse – MST chez la femme, la mère, la mineure, J. Gynecol. Obstet. Biol. Reprod. (Paris), 23, 210\nWitte, 1993, A comparison of pefloxacin\u002Fmetronidazole and doxycyclin\u002Fmetronidazolein the treatment of laparoscopically confirmed acute pelvic inflammatory disease, Eur. J. Obstet. Gynecol. Reprod. Biol., 50, 153, 10.1016\u002F0028-2243(93)90180-K\nJudlin, 2000, Management of pelvic abscesses complicating pelvic inflammatory diseases, Obstet. Gynecol., 95, 56S, 10.1016\u002FS0029-7844(00)00705-5\nTeisala, 1990, Transvaginal ultrasound in the diagnosis and treatment of tubo-ovarian abscess, Br. J. Obstet. Gynaecol., 97, 178, 10.1111\u002Fj.1471-0528.1990.tb01745.x\nGjelland, 2005, Transvaginal ultrasound-guided aspiration for treatment of tubo-ovarian abscess: a study of 302 cases, Am. J. Obstet. Gynecol., 193, 1323, 10.1016\u002Fj.ajog.2005.06.019\nHarisinghani, 2003, Transgluteal approach for percutaneous drainage of deep pelvic abscesses: 154 cases, Radiology, 228, 701, 10.1148\u002Fradiol.2283020924\nHalperin, 2003, Tubo-ovarian abscess in older women: is the womam's age a risk factor for failed response to conservative treatment?, Gynecol. Obstet. Invest., 55, 211, 10.1159\u002F000072076\nHager, 1983, Follow-up of patients with tubo-ovarian abscess(es) in association with salpingitis, Obstet. Gynecol., 61, 680\nBassil, 1991, Place des anti-inflammatoires dans le traitement des salpingites aiguës, J. Gynecol. Obstet. Biol. Reprod. (Paris), 20, 1063\nBruhat, 1989, Infections tubo-péritonéales, 59\nRoberts, 2002, Effects of laparoscopic lavage on adhesion formation and peritoneum in an animal model of pelvic inflammatory disease, J. Am. Assoc. Gynecol. Laparosc., 9, 503, 10.1016\u002FS1074-3804(05)60527-0\nCaul, 1997, Population-based screenings programmes for C. trachomatis, Lancet, 349, 1070, 10.1016\u002FS0140-6736(05)62293-3\nMalkin, 1999, Screening of Chlamydia trachomatis genital infection in a young Parisian population, Sex. Transm. Infect., 75, 188, 10.1136\u002Fsti.75.3.188",{"ES":945},"Infecciones genitales altas",{"VOID":947},"10.1016\u002Fs1283-081x(08)70815-4","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X08708154",[950],{"id":951,"sortIndex":36,"researcher":26,"roles":952,"affiliations":953,"properties":962},"e8336fab-f2f5-4d61-b0cf-da686c143d10",[696],[954],{"id":26,"sortIndex":36,"affiliation":955,"properties":26},{"id":956,"createTime":957,"updateTime":957,"relativeEntities":958,"slug":26,"properties":959,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"88d60848-3e7b-4408-abdc-e7dde6ce851b","2023-12-13T16:17:00.048+00:00",[],{"title":960},{"VI":961},"Clinique universitaire de gynécologie-obstétrique, Maternité régionale de Nancy, 10, rue du Dr Heydenreich CS 74213, 54042 Nancy cedex, France",{"title":963},{"VI":964},"P.-G. Judlin",{"url":948,"publisher":966,"properties":974},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":967,"slug":662,"properties":968,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":971,"manageAffiliations":972,"indexDatabases":973,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":969,"title":970},{"VOID":665},{"EN":667},[],[],[],{"volume":975,"pages":977},{"VOID":976},"44",{"VOID":978},"1-15","2008-01-01",2008,{"id":982,"createTime":983,"updateTime":984,"relativeEntities":985,"slug":986,"properties":987,"entityType":688,"verifyStatus":25,"verifyTime":984,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":994,"fullTextUrl":26,"authors":995,"publicationType":747,"publisherRelationship":1023,"citationCount":26,"citationInfo":26,"publishDate":1036,"publishYear":1037,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"6b3a16f6-6838-4658-995a-00eccda2001d","2024-02-08T14:36:24.912+00:00","2025-01-11T07:00:29.904+00:00",[],"Hemodin%C3%A1mica-fetal",{"references":988,"title":990,"doi":992},{"VOID":989},"Mielke, 2001, Cardiac output and central distribution of blood flow in the human fetus, Circulation, 103, 1662, 10.1161\u002F01.CIR.103.12.1662\nKiserud, 2004, The fetal circulation, Prenat. Diagn., 24, 1049, 10.1002\u002Fpd.1062\nBellotti, 2000, Role of ductus venosus in distribution of umbilical blood flow in human fetuses during second half of pregnancy, Am. J. Physiol. Heart Circ. Physiol., 279, H1256, 10.1152\u002Fajpheart.2000.279.3.H1256\nKiserud, 2000, Blood flow and the degree of shunting through the ductus venosus in the human fetus, Am. J. Obstet. Gynecol., 182, 147, 10.1016\u002FS0002-9378(00)70504-7\nRudolph, 1991, Effects of ductus venosus obstruction on liver and regional blood flows in the fetal lamb, Pediatr. Res., 29, 347, 10.1203\u002F00006450-199104000-00004\nTchirikov, 2001, Obstruction of ductus venosus stimulates cell proliferation in organs of fetal sheep, Placenta, 22, 24, 10.1053\u002Fplac.2000.0585\nKiserud, 2000, Effect of NO, phenylephrine, and hypoxemia on ductus venosus diameter in fetal sheep, Am. J. Physiol. Heart Circ. Physiol., 279, H1166, 10.1152\u002Fajpheart.2000.279.3.H1166\nKiserud, 1997, Umbilical flow distribution to the liver and the ductus venosus: an in vitro investigation of the fluid dynamic mechanisms in the fetal sheep, Am. J. Obstet. Gynecol., 177, 86, 10.1016\u002FS0002-9378(97)70442-3\nKiserud, 2001, Ultrasound assessment of the fetal foramen ovale, Ultrasound Obstet. Gynecol., 17, 119, 10.1046\u002Fj.1469-0705.2001.00331.x\nWallen, 1990, Morphometric study of the role of pulmonary arterial flow in fetal lung growth in sheep, Pediatr. Res., 27, 122, 10.1203\u002F00006450-199002000-00004\nRasanen, 1998, Reactivity of the human fetal pulmonary circulation to maternal hyperoxygenation increases during the second half of pregnancy: a randomized study, Circulation, 97, 257, 10.1161\u002F01.CIR.97.3.257\nFouron, 1994, Flow velocity profile of the fetal aortic isthmus through normal gestation, Am. J. Cardiol., 74, 483, 10.1016\u002F0002-9149(94)90908-3\nMakikallio, 2002, Retrograde net blood flow in the aortic isthmus in relation to human fetal arterial and venous circulations, Ultrasound Obstet. Gynecol., 19, 147, 10.1046\u002Fj.0960-7692.2001.00626.x\nTeitel, 1987, Effects of birth-related events on central blood flow patterns, Pediatr. Res., 22, 557, 10.1203\u002F00006450-198711000-00017\nThornburg, 1983, Filling and arterial pressures as determinants of RV stroke volume in the sheep fetus, Am. J. Physiol., 244, H656\nJohnson, 2000, Intracardiac pressures in the human fetus, Heart, 84, 59, 10.1136\u002Fheart.84.1.59\nBoito, 2002, Umbilical venous volume flow in the normally developing and growth-restricted human fetus, Ultrasound Obstet. Gynecol., 19, 344, 10.1046\u002Fj.1469-0705.2002.00671.x\nRudolph, 1985, Distribution and regulation of blood flow in the fetal and neonatal lamb, Circ. Res., 57, 811, 10.1161\u002F01.RES.57.6.811\nAdamson, 1999, Arterial pressure, vascular input impedance, and resistance as determinants of pulsatile blood flow in the umbilical artery, Eur. J. Obstet. Gynecol. Reprod. Biol., 84, 119, 10.1016\u002FS0301-2115(98)00320-0\nHanson, 1997, Do we now understand the control of the fetal circulation?, Eur. J. Obstet. Gynecol. Reprod. Biol., 75, 55, 10.1016\u002FS0301-2115(97)00203-0\nFisher, 1982, Fetal myocardial oxygen and carbohydrate metabolism in sustained hypoxemia in utero, Am. J. Physiol., 243, H959\nBaschat, 2000, Coronary artery blood flow visualization signifies hemodynamic deterioration in growth-restricted fetuses, Ultrasound Obstet. Gynecol., 16, 425, 10.1046\u002Fj.1469-0705.2000.00237.x\nWladimiroff, 1987, Cerebral and umbilical arterial blood flow velocity waveforms in normal and growth-retarded pregnancies, Obstet. Gynecol., 69, 705\nSidi, 1983, Developmental changes in oxygenation and circulatory responses to hypoxemia in lambs, Am. J. Physiol., 245, H674\nBricker, 2000, Ultrasound screening in pregnancy: a systematic review of the clinical effectiveness, cost-effectiveness and women's views, Health Technol Assess, 4, 1\nArbeille, 1997, Fetal arterial Doppler-IUGR and hypoxia, Eur. J. Obstet. Gynecol. Reprod. Biol., 75, 51, 10.1016\u002FS0301-2115(97)00202-9\nKarsdorp, 1994, Clinical significance of absent or reversed end diastolic velocity waveforms in umbilical artery, Lancet, 344, 1664, 10.1016\u002FS0140-6736(94)90457-X\nNeilson, 2000, Doppler ultrasound for fetal assessment in high risk pregnancies, Cochrane Database Syst. Rev., 2\nArduini, 1993, The development of abnormal heart rate patterns after absent end-diastolic velocity in umbilical artery: analysis of risk factors, Am. J. Obstet. Gynecol., 168, 43, 10.1016\u002FS0002-9378(12)90882-0\n1997, A randomised controlled trial of Doppler ultrasound velocimetry of the umbilical artery in low risk pregnancies, Br. J. Obstet. Gynaecol., 104, 419, 10.1111\u002Fj.1471-0528.1997.tb11492.x\nGoffinet, 1997, Clinical value of umbilical Doppler. Results of controlled trials in high risk and low risk populations, J. Gynecol. Obstet. Biol. Reprod. (Paris), 26, 16\nGoffinet, 1997, Umbilical artery Doppler velocimetry in unselected and low risk pregnancies: a review of randomised controlled trials, Br. J. Obstet. Gynaecol., 104, 425, 10.1111\u002Fj.1471-0528.1997.tb11493.x\nArbeille, 1987, Doppler examination of the umbilical and cerebral arterial circulation of the fetus, J. Gynecol. Obstet. Biol. Reprod. (Paris), 16, 45\nBonnin, 1992, Relationship between umbilical and fetal cerebral blood flow velocity waveforms and umbilical venous blood gases, Ultrasound Obstet. Gynecol., 2, 18, 10.1046\u002Fj.1469-0705.1992.02010018.x\nRudigoz, 1992, Diagnostic and prognostic value of umbilical and cerebral Doppler velocimetry in intrauterine growth retardation, Rev. Fr. Gynecol. Obstet., 87, 335\nArduini, 1993, Doppler studies of deteriorating growth-retarded fetuses, Curr. Opin. Obstet. Gynecol., 5, 195, 10.1097\u002F00001703-199304000-00005\nKurmanavicius, 2001, Reference values of fetal peak systolic blood flow velocity in the middle cerebral artery at 19-40 weeks of gestation, Ultrasound Obstet. Gynecol., 17, 50, 10.1046\u002Fj.1469-0705.2001.00311.x\nMari, 1995, Diagnosis of fetal anemia with Doppler ultrasound in the pregnancy complicated by maternal blood group immunization, Ultrasound Obstet. Gynecol., 5, 400, 10.1046\u002Fj.1469-0705.1995.05060400.x\nMari, 2000, Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses, N. Engl. J. Med., 342, 9, 10.1056\u002FNEJM200001063420102\nMari, 2002, Accurate prediction of fetal hemoglobin by Doppler ultrasonography, Obstet. Gynecol., 99, 589, 10.1016\u002FS0029-7844(01)01783-5\nScheier, 2004, Prediction of fetal anemia in rhesus disease by measurement of fetal middle cerebral artery peak systolic velocity, Ultrasound Obstet. Gynecol., 23, 432, 10.1002\u002Fuog.1010\nBullock, 2005, Prediction of fetal anemia in pregnancies with red-cell alloimmunization: comparison of middle cerebral artery peak systolic velocity and amniotic fluid OD450, Ultrasound Obstet. Gynecol., 25, 331, 10.1002\u002Fuog.1886\nDeren, 2002, The value of middle cerebral artery systolic velocity for initial and subsequent management in fetal anemia, Eur. J. Obstet. Gynecol. Reprod. Biol., 101, 26, 10.1016\u002FS0301-2115(01)00501-2\nStefos, 2002, Correction of fetal anemia on the middle cerebral artery peak systolic velocity, Obstet. Gynecol., 99, 211, 10.1016\u002FS0029-7844(01)01724-0\nFouron, 1999, Relationship between flow through the fetal aortic isthmus and cerebral oxygenation during acute placental circulatory insufficiency in ovine fetuses, Am. J. Obstet. Gynecol., 181, 1102, 10.1016\u002FS0002-9378(99)70089-X\nFouron, 2001, Correlation between prenatal velocity waveforms in the aortic isthmus and neurodevelopmental outcome between the ages of 2 and 4 years, Am. J. Obstet. Gynecol., 184, 630, 10.1067\u002Fmob.2001.110696\nFuke, 2003, Antenatal prediction of pulmonary hypoplasia by acceleration time\u002Fejection time ratio of fetal pulmonary arteries by Doppler blood flow velocimetry, Am. J. Obstet. Gynecol., 188, 228, 10.1067\u002Fmob.2003.69\nBroth, 2002, Prenatal prediction of lethal pulmonary hypoplasia: the hyperoxygenation test for pulmonary artery reactivity, Am. J. Obstet. Gynecol., 187, 940, 10.1067\u002Fmob.2002.127130\nHofstaetter, 2001, Two types of umbilical venous pulsations and outcome of high-risk pregnancy, Early Hum. Dev., 61, 111, 10.1016\u002FS0378-3782(00)00126-2\nReed, 1997, Umbilical venous velocity pulsations are related to atrial contraction pressure waveforms in fetal lambs, Obstet. Gynecol., 89, 953, 10.1016\u002FS0029-7844(97)00154-3\nGudmundsson, 1999, Importance of venous flow assessment for clinical decision-making, Eur. J. Obstet. Gynecol. Reprod. Biol., 84, 173, 10.1016\u002FS0301-2115(98)00326-1\nGagnon, 1997, Cerebral circulatory responses of near-term ovine fetuses during sustained fetal placental embolization, Am. J. Physiol., 273, H2001\nRizzo, 1995, The value of fetal arterial, cardiac and venous flows in predicting pH and blood gases measured in umbilical blood at cordocentesis in growth retarded fetuses, Br. J. Obstet. Gynaecol., 102, 963, 10.1111\u002Fj.1471-0528.1995.tb10903.x\nBilardo, 2004, Relationship between monitoring parameters and perinatal outcome in severe, early intrauterine growth restriction, Ultrasound Obstet. Gynecol., 23, 119, 10.1002\u002Fuog.965\nOzcan, 1998, Arterial and venous Doppler velocimetry in the severely growth-restricted fetus and associations with adverse perinatal outcome, Ultrasound Obstet. Gynecol., 12, 39, 10.1046\u002Fj.1469-0705.1998.12010039.x",{"ES":991},"Hemodinámica fetal",{"VOID":993},"10.1016\u002Fs1283-081x(06)47737-7","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X06477377",[996,1011],{"id":997,"sortIndex":36,"researcher":26,"roles":998,"affiliations":999,"properties":1008},"5c765793-db7e-4c78-8524-efcd83b90b42",[696],[1000],{"id":26,"sortIndex":36,"affiliation":1001,"properties":26},{"id":1002,"createTime":1003,"updateTime":1003,"relativeEntities":1004,"slug":26,"properties":1005,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"50684d3f-030a-43eb-90ac-2c9aeace6a06","2024-02-08T14:36:24.942+00:00",[],{"title":1006},{"VI":1007},"Département de périnatologie, hôpital Jeanne de Flandre, CHRU de Lille, 59037 Lille cedex, France",{"title":1009},{"VI":1010},"P. Deruelle",{"id":1012,"sortIndex":115,"researcher":26,"roles":1013,"affiliations":1014,"properties":1020},"991c3f88-65df-48bd-a446-7fec243a037a",[696],[1015],{"id":26,"sortIndex":36,"affiliation":1016,"properties":26},{"id":1002,"createTime":1003,"updateTime":1003,"relativeEntities":1017,"slug":26,"properties":1018,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1019},{"VI":1007},{"title":1021},{"VI":1022},"L. Storme",{"url":994,"publisher":1024,"properties":1032},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1025,"slug":662,"properties":1026,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1029,"manageAffiliations":1030,"indexDatabases":1031,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1027,"title":1028},{"VOID":665},{"EN":667},[],[],[],{"volume":1033,"pages":1035},{"VOID":1034},"42",{"VOID":932},"2006-01-01",2006,{"id":1039,"createTime":1040,"updateTime":1041,"relativeEntities":1042,"slug":1043,"properties":1044,"entityType":688,"verifyStatus":25,"verifyTime":1041,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":115,"primaryUrl":1051,"fullTextUrl":26,"authors":1052,"publicationType":747,"publisherRelationship":1179,"citationCount":26,"citationInfo":26,"publishDate":979,"publishYear":980,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"685c10b1-ef75-4288-a275-04c7b3e0894d","2024-02-14T04:35:30.152+00:00","2025-01-26T10:48:59.293+00:00",[],"Laparoscopia-y-cirug%C3%ADa-laparosc%C3%B3pica-principios-generales-e-instrumental",{"references":1045,"title":1047,"doi":1049},{"VOID":1046},"Palmer, 1948, La cœlioscopie, Bruxells Med., 28, 305\nBruhat, 1979, Essai d'un traitement per cœlioscopique de la grossesse extra-utérine : à propos de 26 observations, Rev. Fr. Gynecol. Obstet., 72, 667\nReich, 1989, Laparoscopic hysterectomy, J. Gynecol. Surg., 5, 213, 10.1089\u002Fgyn.1989.5.213\nwww.websurg.com.\nBruhat, 1991\nHolzer, 2006, Laparoscopic versus open myomectomy: a double-blind study to evaluate postoperative pain, Anesth. Analg., 102, 1480, 10.1213\u002F01.ane.0000204321.85599.0d\nGarry, 2006, Laparoscopic surgery, Best Pract. Res. Clin. Obstet. Gynecol., 20, 89, 10.1016\u002Fj.bpobgyn.2005.10.003\nGarry, 1997, Complications of laparoscopic entry, Gynecol. Endosc., 6, 319, 10.1111\u002Fj.1365-2508.1997.151-gy0558.x\nQuerleu, 1993, Complications of gynaecological laparoscopic surgery: a French collaborative study, Gynecol. Endosc., 2, 3\nChapron, 1998, Surgical complications of diagnostic and operative gynaecological laparoscopy. A series of 29 966 cases, Hum. Reprod., 13, 867, 10.1093\u002Fhumrep\u002F13.4.867\nMenes, 2000, Laparoscopy: searching for the proper insufflation gas, Surg. Endosc., 14, 1050, 10.1007\u002Fs004640000216\nGutt, 2004, Circulatory and respiratory complications of carbon dioxide insufflation, Dig. Surg., 21, 95, 10.1159\u002F000077038\nElkelani, 2004, Effect of adding more than 3% oxygen to carbon dioxide pneumoperitoneum on adhesion formation in a laparoscopic mouse model, Fertil. Steril., 82, 1616, 10.1016\u002Fj.fertnstert.2004.07.933\nLarsen, 2004, Randomized clinical trial of the effect of pneumoperitoneum on cardiac function and haemodynamics during laparoscopic cholecystectomy, Br. J. Surg., 91, 848, 10.1002\u002Fbjs.4573\nAlijani, 2004, Abdominal wall lift versus positive-pressure capnoperitoneum for laparoscopic cholecystectomy: randomized controlled trial, Ann. Surg., 239, 388, 10.1097\u002F01.sla.0000114226.31773.e3\nNeudecker, 2002, The European Association for Endoscopic Surgery clinical practice guideline on the pneumoperitoneum for laparoscopic surgery, Surg. Endosc., 16, 1121, 10.1007\u002Fs00464-001-9166-7\nMalik, 2000, Fluorescence diagnosis of endometriosis using 5-aminolevulinic acid, Surg. Endosc., 14, 452, 10.1007\u002Fs004640000160\nLöning, 2004, Laparoscopic fluorescence detection of ovarian carcinoma metastases using 5-aminolevulinic acid-induced protoporphyrin IX, Cancer, 100, 1650, 10.1002\u002Fcncr.20155\nBuchweitz, 2006, Detection of peritoneal endometriotic lesions by autofluorescence laparoscopy, Am. J. Obstet. Gynecol., 195, 949, 10.1016\u002Fj.ajog.2006.02.044\nKadar, 1993, Incisional hernias after major laparoscopic gynecologic procedures, Am. J. Obstet. Gynecol., 168, 1493, 10.1016\u002FS0002-9378(11)90787-X\nSinghvi, 2002, Assessment of the physical properties of endoscopic retrieval systems, Br. J. Surg., 89, 1183, 10.1046\u002Fj.1365-2168.2002.02192.x\nKöchli, 2000, Endobag extractor to remove masses during laparoscopy, Obstet. Gynecol., 95, 304\nHarold, 2003, Comparison of ultrasonic energy, bipolar thermal energy, and vascular clips for the hemostasis of small-, medium-, and large-sized arteries, Surg. Endosc., 17, 1228, 10.1007\u002Fs00464-002-8833-7\nDiamantis, 2006, Comparison of monopolar electrocoagulation, bipolar electrocoagulation, ultracision, and ligasure, Surg. Today, 36, 908, 10.1007\u002Fs00595-006-3254-1\nEmam, 2003, How safe is high-power ultrasonic dissection?, Ann. Surg., 237, 186, 10.1097\u002F01.SLA.0000048454.11276.62\nHensman, 1998, Chemical composition of smoke produced by high-frequency electrosurgery in a closed gaseous environment: an in-vitro study, Surg. Endosc., 12, 1017, 10.1007\u002Fs004649900771\n2006, Control and prevention of peritoneal adhesions in gynecologic surgery, Fertil. Steril., 86, S1, 10.1016\u002Fj.fertnstert.2006.07.1483\nAit Menguellet, 2007, Interest in agents for adhesion prevention after gynecologic surgery, Gynecol. Obstet. Fertil., 35, 290, 10.1016\u002Fj.gyobfe.2007.02.011\nBrown CB, Luciano AA, Martin D, Peers E, Scrimgeour A, Dizerega GS; on behalf of the Adept Adhesion Reduction Study Group. Adept (icodextrin 4% solution) reduces adhesions after laparoscopic surgery for adhesiolysis: a double-blind, randomized, controlled study. Fertil. Steril. 2007; (Mar23;[Epub ahead of print]).",{"ES":1048},"Laparoscopia y cirugía laparoscópica: principios generales e instrumental",{"VOID":1050},"10.1016\u002Fs1283-081x(08)70808-7","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X08708087",[1053,1068,1080,1092,1104,1119,1131,1143,1155,1167],{"id":1054,"sortIndex":52,"researcher":26,"roles":1055,"affiliations":1056,"properties":1065},"c8c8b4c6-cad9-47b1-88b4-2fa9709cd311",[696],[1057],{"id":26,"sortIndex":36,"affiliation":1058,"properties":26},{"id":1059,"createTime":1060,"updateTime":1060,"relativeEntities":1061,"slug":26,"properties":1062,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"85222ac4-6572-4fda-bf7c-ff8b8443aea4","2024-02-14T04:35:30.184+00:00",[],{"title":1063},{"VI":1064},"Centre hospitalier universitaire de Clermont-Ferrand, Polyclinique de l'Hôtel-Dieu, service de gynécologie obstétrique et médecine de la reproduction, boulevard Léon-Malfreyt, 63000 Clermont-Ferrand, France",{"title":1066},{"VI":1067},"M. Canis",{"id":1069,"sortIndex":162,"researcher":26,"roles":1070,"affiliations":1071,"properties":1077},"a58dd99f-be9e-4f4c-be9a-25dc0e5d3625",[696],[1072],{"id":26,"sortIndex":36,"affiliation":1073,"properties":26},{"id":1059,"createTime":1060,"updateTime":1060,"relativeEntities":1074,"slug":26,"properties":1075,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1076},{"VI":1064},{"title":1078},{"VI":1079},"B. Rabischong",{"id":1081,"sortIndex":115,"researcher":26,"roles":1082,"affiliations":1083,"properties":1089},"87b8574f-629e-448c-8dd5-2c74efe52dd4",[696],[1084],{"id":26,"sortIndex":36,"affiliation":1085,"properties":26},{"id":1059,"createTime":1060,"updateTime":1060,"relativeEntities":1086,"slug":26,"properties":1087,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1088},{"VI":1064},{"title":1090},{"VI":1091},"L. Velemir",{"id":1093,"sortIndex":158,"researcher":26,"roles":1094,"affiliations":1095,"properties":1101},"aa307ae0-1c39-41bf-9b5d-d85b078d85f5",[696],[1096],{"id":26,"sortIndex":36,"affiliation":1097,"properties":26},{"id":1059,"createTime":1060,"updateTime":1060,"relativeEntities":1098,"slug":26,"properties":1099,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1100},{"VI":1064},{"title":1102},{"VI":1103},"J.-L. Pouly",{"id":1105,"sortIndex":114,"researcher":26,"roles":1106,"affiliations":1107,"properties":1116},"f9e4efa3-0037-48b4-ac7f-412129e460e9",[696],[1108],{"id":26,"sortIndex":36,"affiliation":1109,"properties":26},{"id":1110,"createTime":1111,"updateTime":1111,"relativeEntities":1112,"slug":26,"properties":1113,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"b293de01-17b5-4cbf-ba79-716d1d09c39d","2024-02-14T04:35:30.198+00:00",[],{"title":1114},{"VI":1115},"Centre hospitalier universitaire de Strasbourg, service de gynécologie-obstétrique, 1, place de l'Hôpital, 67000 Strasbourg cedex, France",{"title":1117},{"VI":1118},"A. Wattiez",{"id":1120,"sortIndex":50,"researcher":26,"roles":1121,"affiliations":1122,"properties":1128},"59add75c-c97b-4abc-abff-ded75ae3ae12",[696],[1123],{"id":26,"sortIndex":36,"affiliation":1124,"properties":26},{"id":1059,"createTime":1060,"updateTime":1060,"relativeEntities":1125,"slug":26,"properties":1126,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1127},{"VI":1064},{"title":1129},{"VI":1130},"G. Mage",{"id":1132,"sortIndex":111,"researcher":26,"roles":1133,"affiliations":1134,"properties":1140},"f8509d99-5fd4-480b-9475-73f76ed302c4",[696],[1135],{"id":26,"sortIndex":36,"affiliation":1136,"properties":26},{"id":1059,"createTime":1060,"updateTime":1060,"relativeEntities":1137,"slug":26,"properties":1138,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1139},{"VI":1064},{"title":1141},{"VI":1142},"F. Bolandard",{"id":1144,"sortIndex":36,"researcher":26,"roles":1145,"affiliations":1146,"properties":1152},"146c4216-24f6-4d94-8f77-0d3dc19e95ff",[696],[1147],{"id":26,"sortIndex":36,"affiliation":1148,"properties":26},{"id":1059,"createTime":1060,"updateTime":1060,"relativeEntities":1149,"slug":26,"properties":1150,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1151},{"VI":1064},{"title":1153},{"VI":1154},"R. Botchorishvili",{"id":1156,"sortIndex":59,"researcher":26,"roles":1157,"affiliations":1158,"properties":1164},"f1fab820-877b-401f-b071-e34df3023ec3",[696],[1159],{"id":26,"sortIndex":36,"affiliation":1160,"properties":26},{"id":1059,"createTime":1060,"updateTime":1060,"relativeEntities":1161,"slug":26,"properties":1162,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1163},{"VI":1064},{"title":1165},{"VI":1166},"X. Tran",{"id":1168,"sortIndex":135,"researcher":26,"roles":1169,"affiliations":1170,"properties":1176},"e93b2b92-376f-4527-b159-2edb6a808f2a",[696],[1171],{"id":26,"sortIndex":36,"affiliation":1172,"properties":26},{"id":1059,"createTime":1060,"updateTime":1060,"relativeEntities":1173,"slug":26,"properties":1174,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1175},{"VI":1064},{"title":1177},{"VI":1178},"K. Jardon",{"url":1051,"publisher":1180,"properties":1188},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1181,"slug":662,"properties":1182,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1185,"manageAffiliations":1186,"indexDatabases":1187,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1183,"title":1184},{"VOID":665},{"EN":667},[],[],[],{"volume":1189,"pages":1190},{"VOID":976},{"VOID":978},{"id":1192,"createTime":1193,"updateTime":1194,"relativeEntities":1195,"slug":1196,"properties":1197,"entityType":688,"verifyStatus":25,"verifyTime":1194,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1204,"fullTextUrl":26,"authors":1205,"publicationType":747,"publisherRelationship":1281,"citationCount":26,"citationInfo":26,"publishDate":933,"publishYear":934,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"06058d57-08af-47b2-998c-be20b2be0e34","2023-12-13T13:35:41.698+00:00","2025-01-11T17:50:30.306+00:00",[],"Utilidad-de-la-histeroscopia-diagn%C3%B3stica-en-el-estudio-de-la-infertilidad",{"references":1198,"title":1200,"doi":1202},{"VOID":1199},"Merviel, 2000, Place de l'hystéroscopie dans le diagnostic et le traitement de l'infertilité, Presse Méd., 29, 1302\nPrevedourakis, 1994, Hysterosalpingography and hysteroscopy in female infertility, Hum. Reprod., 9, 2353, 10.1093\u002Foxfordjournals.humrep.a138451\nPreutthipan, 2003, A prospective study between hysterosalpingography and hysteroscopy in the detection of intrauterine pathology in patients with infertility, J. Obstet. Gynaecol. Res., 29, 33, 10.1046\u002Fj.1341-8076.2003.00068.x\nWang, 1996, Comparison of hysterosalpingography and hysteroscopy in infertility, J. Am. Assoc. Gynecol. Laparosc., 3, 581, 10.1016\u002FS1074-3804(05)80170-7\nGolan, 1996, Hysteroscopy is superior to hysterosalpingography in infertility investigation, Acta Obstet. Gynecol. Scand., 75, 654, 10.3109\u002F00016349609054692\nLoverro, 2001, Uterine cavity assessment in infertile women: comparison of transvaginal sonography and hysteroscopy, Eur. J. Obstet. Gynecol. Reprod. Biol., 100, 67, 10.1016\u002FS0301-2115(01)00434-1\nShalev, 2000, Predictive value of transvaginal sonography performed before routine diagnostic hysteroscopy for evaluation of infertility, Fertil. Steril., 73, 412, 10.1016\u002FS0015-0282(99)00533-6\nNarayan, 1993, Transvaginal sonography of the uterine cavity with hysteroscopic correlation in the investigation of infertility, Ultrasound Obstet. Gynecol., 3, 129, 10.1046\u002Fj.1469-0705.1993.03020129.x\nSoares, 2000, Diagnostic accuracy of sonohysterography, transvaginal sonography, and hysterosalpingography in patients with uterine cavity diseases, Fertil. Steril., 73, 406, 10.1016\u002FS0015-0282(99)00532-4\nHamilton, 1998, Routine use of saline hysterosonography in 500 consecutive, unselected, infertile women, Hum. Reprod., 13, 2463, 10.1093\u002Fhumrep\u002F13.9.2463\nDe Kroon, 2003, Technology assessment of saline contrast hysterosonography, Am. J. Obstet. Gynecol., 188, 945, 10.1067\u002Fmob.2003.264\nBrown, 2000, Evaluation of outpatient hysteroscopy,sline infusion hysterosonography,and hysterosalpingography in infertile women: a prospective, randomized study, Fertil. Steril., 74, 1029, 10.1016\u002FS0015-0282(00)01541-7\nAyida, 1997, Uterine cavity assessment prior to in vitro fertilization: comparison of transvaginal scanning, saline contrast hysterosonography and hysteroscopy, Ultrasound Obstet. Gynecol., 10, 59, 10.1046\u002Fj.1469-0705.1997.10010059.x\nLeone, 2003, Use of strict sonohysterographic methods for preoperative assessment of submucous myomas, Fertil. Steril., 79, 998, 10.1016\u002FS0015-0282(02)04916-6\nGronlund, 1999, Transvaginal sonohysterography and hysteroscopy in the evaluation of female infertility, habitual abortion or metrorrhagia. A comparative study, Acta Obstet. Gynecol. Scand., 78, 415, 10.1080\u002Fj.1600-0412.1999.780513.x\nAlatas, 1997, Evaluation of intrauterine abnormalities in infertile patients by sonohysterography, Hum. Reprod., 12, 487, 10.1093\u002Fhumrep\u002F12.3.487\nSchrager, 2004, Diethylstilbestrol exposure, Am. Fam. Physician., 69, 2395\nLitta, 2004, Hysteroscopic metroplasty under laparoscopic guidance in infertile women with septate uteri: follow-up of reproductive outcome, J. Reprod. Med., 49, 274\nKdous, 2003, Fertility after hysteroscopic treatment of intra-uterine adhesions, Gynecol. Obstet. Fertil., 31, 422, 10.1016\u002FS1297-9589(03)00101-2\nSchiano, 1999, The value of hysteroscopy after repeated implantation failures with in vitro fertilization, Contracept. Fertil. Sex., 27, 129\nFeghali, 2003, Systematic hysteroscopy prior to in vitro fertilization, Gynecol. Obstet Fertil., 31, 127\nSeneira, 1988, Hysteroscopy in an IVF-ER program, Acta Obstet. Gynecol. Scand., 67, 654\nLa Sala, 1985, Hysteroscopy and female sterility: analysis of the results from 213 patients, Acta Eur. Fertil., 16, 47\nShamma, 1992, The role of office hysteroscopy in in vitro fertilization, Fertil. Steril., 58, 1237, 10.1016\u002FS0015-0282(16)55576-9",{"ES":1201},"Utilidad de la histeroscopia diagnóstica en el estudio de la infertilidad",{"VOID":1203},"10.1016\u002Fs1283-081x(05)43391-3","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X05433913",[1206,1221,1233,1245,1257,1269],{"id":1207,"sortIndex":115,"researcher":26,"roles":1208,"affiliations":1209,"properties":1218},"d6dbd2e1-8558-4eac-a153-334c9e2c8fb1",[696],[1210],{"id":26,"sortIndex":36,"affiliation":1211,"properties":26},{"id":1212,"createTime":1213,"updateTime":1213,"relativeEntities":1214,"slug":26,"properties":1215,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"c372a8a2-1ab7-4b14-87b8-11b2ea4d64de","2023-12-13T13:35:41.742+00:00",[],{"title":1216},{"VI":1217},"Service de gynécologie obstétrique, hôpital La Conception, 147, boulevard Baille, Marseille 13005, France",{"title":1219},{"VI":1220},"F. Franchi",{"id":1222,"sortIndex":59,"researcher":26,"roles":1223,"affiliations":1224,"properties":1230},"cd449751-51dc-415e-84fe-71c7b6ee58d3",[696],[1225],{"id":26,"sortIndex":36,"affiliation":1226,"properties":26},{"id":1212,"createTime":1213,"updateTime":1213,"relativeEntities":1227,"slug":26,"properties":1228,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1229},{"VI":1217},{"title":1231},{"VI":1232},"V. Roger",{"id":1234,"sortIndex":111,"researcher":26,"roles":1235,"affiliations":1236,"properties":1242},"9290bb5b-fba7-4447-98f7-a095174ee880",[696],[1237],{"id":26,"sortIndex":36,"affiliation":1238,"properties":26},{"id":1212,"createTime":1213,"updateTime":1213,"relativeEntities":1239,"slug":26,"properties":1240,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1241},{"VI":1217},{"title":1243},{"VI":1244},"L. Cravello",{"id":1246,"sortIndex":36,"researcher":26,"roles":1247,"affiliations":1248,"properties":1254},"11aa1753-fcad-4bb2-b44d-0993f05ef7ae",[696],[1249],{"id":26,"sortIndex":36,"affiliation":1250,"properties":26},{"id":1212,"createTime":1213,"updateTime":1213,"relativeEntities":1251,"slug":26,"properties":1252,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1253},{"VI":1217},{"title":1255},{"VI":1256},"A. Agostini",{"id":1258,"sortIndex":162,"researcher":26,"roles":1259,"affiliations":1260,"properties":1266},"d18fbdec-9958-4c3d-8502-5a77de4309ee",[696],[1261],{"id":26,"sortIndex":36,"affiliation":1262,"properties":26},{"id":1212,"createTime":1213,"updateTime":1213,"relativeEntities":1263,"slug":26,"properties":1264,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1265},{"VI":1217},{"title":1267},{"VI":1268},"B. Blanc",{"id":1270,"sortIndex":114,"researcher":26,"roles":1271,"affiliations":1272,"properties":1278},"8be28c33-f4a2-4308-bbdc-282c87c480c5",[696],[1273],{"id":26,"sortIndex":36,"affiliation":1274,"properties":26},{"id":1212,"createTime":1213,"updateTime":1213,"relativeEntities":1275,"slug":26,"properties":1276,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1277},{"VI":1217},{"title":1279},{"VI":1280},"F. Bretelle",{"url":1204,"publisher":1282,"properties":1290},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1283,"slug":662,"properties":1284,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1287,"manageAffiliations":1288,"indexDatabases":1289,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1285,"title":1286},{"VOID":665},{"EN":667},[],[],[],{"volume":1291,"pages":1292},{"VOID":930},{"VOID":1293},"1-4",{"id":1295,"createTime":1296,"updateTime":1297,"relativeEntities":1298,"slug":1299,"properties":1300,"entityType":688,"verifyStatus":25,"verifyTime":1297,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":115,"primaryUrl":1307,"fullTextUrl":26,"authors":1308,"publicationType":747,"publisherRelationship":1380,"citationCount":26,"citationInfo":26,"publishDate":1394,"publishYear":1395,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"026c9691-1dae-44b9-a2f8-c55c97b73d3f","2024-02-13T14:54:18.979+00:00","2025-01-27T08:28:40.330+00:00",[],"Histeroscopia-quir%C3%BArgica",{"references":1301,"title":1303,"doi":1305},{"VOID":1302},"Neveu, 2017, Standardizing hysteroscopy teaching: development of a curriculum using the Delphi method, Surg Endosc, 31, 5389, 10.1007\u002Fs00464-017-5620-z\nLopes, 2017, An overview of the results of hysterosonography prior to in vitro fertilization, JBRA Assist Reprod, 21, 302\nBouzid, 2016, Feasibility and diagnostic value of hysterosonography performed in bleeding time in the exploration of abnormal uterine bleeding, J Gynecol Obstet Biol Reprod, 45, 1067, 10.1016\u002Fj.jgyn.2016.03.008\nde Kroon, 2003, Saline contrast hysterosonography in abnormal uterine bleeding: a systematic review and meta-analysis, Int J Obstet Gynaecol, 110, 938, 10.1111\u002Fj.1471-0528.2003.02472.x\nDudiak, 2001, Hysterosonography: a key to what is inside the uterus, Ultrasound Q, 17, 73, 10.1097\u002F00013644-200106000-00002\nDeffieux, 2013, Prevention of the complications related to hysteroscopy: guidelines for clinical practice, J Gynecol Obstet Biol Reprod, 42, 1032, 10.1016\u002Fj.jgyn.2013.09.008\nDreisler, 2019, Asherman's syndrome: current perspectives on diagnosis and management, Int J Womens Health, 11, 191, 10.2147\u002FIJWH.S165474\nSalle, 1999, Transvaginal sonohysterographic evaluation of intrauterine adhesions, J Clin Ultrasound, 27, 131, 10.1002\u002F(SICI)1097-0096(199903\u002F04)27:3\u003C131::AID-JCU5>3.0.CO;2-3\nSoares, 2000, Diagnostic accuracy of sonohysterography, transvaginal sonography, and hysterosalpingography in patients with uterine cavity diseases, Fertil Steril, 73, 406, 10.1016\u002FS0015-0282(99)00532-4\nBerridge, 2004, Saline infusion sonohysterography: technique, indications, and imaging findings, J Ultrasound Med, 23, 97, 10.7863\u002Fjum.2004.23.1.97\nSabry, 2018, Diagnostic value of three-dimensional saline infusion sonohysterography in the evaluation of the uterus and uterine cavity lesions, Pol J Radiol, 83, e482, 10.5114\u002Fpjr.2018.80132\nWamsteker, 1988, Diagnostic and therapeutic applications of hysteroscopy, Ned Tijdschr Geneeskd, 132, 2041\nCapella-Allouc, 1999, Hysteroscopic treatment of severe Asherman's syndrome and subsequent fertility, Hum Reprod, 14, 1230, 10.1093\u002Fhumrep\u002F14.5.1230\nFernandez, 2012, Total adhesions treated by hysteroscopy: must we stop at two procedures?, Fertil Steril, 98, 980, 10.1016\u002Fj.fertnstert.2012.06.032\nThubert, 2015, Influence of auto-cross-linked hyaluronic acid gel on pregnancy rate and hysteroscopic outcomes following surgical removal of intra-uterine adhesions, Eur J Obstet Gynecol Reprod Biol, 193, 65, 10.1016\u002Fj.ejogrb.2015.06.025\nWarembourg, 2015, Prevention and treatment of intra-uterine synechiae: review of the literature, J Gynecol Obstet Biol Reprod, 44, 366, 10.1016\u002Fj.jgyn.2014.10.014\nZhang, 2018, Therapeutic effect of human umbilical cord-derived mesenchymal stem cells on injured rat endometrium during its chronic phase, Stem Cell Res Ther, 9, 36, 10.1186\u002Fs13287-018-0777-5\nFernandez, 2012, Post-curettage and aspiration synechiae: is there value in an anti-adhesion agent?, J Gynecol Obstet Biol Reprod, 41, H8, 10.1016\u002FS0368-2315(12)70004-2\nGrimbizis, 2013, The ESHRE-ESGE consensus on the classification of female genital tract congenital anomalies, Gynecol Surg, 10, 199, 10.1007\u002Fs10397-013-0800-x\nRikken, 2018, The randomised uterine septum transsection trial (TRUST): design and protocol, BMC Womens Health, 18, 1, 10.1186\u002Fs12905-018-0637-6\nGarbin, 1997, Transcervical hysteroplasty: indications, techniques and results. 125 cases, Contracept Fertil Sex, 25, 843\nNagel, 1993, Hysteroscopic metroplasty in the diethylstilbestrol-exposed uterus and similar nonfusion anomalies: effects on subsequent reproductive performance; a preliminary report, Fertil Steril, 59, 502, 10.1016\u002FS0015-0282(16)55789-6\nFernandez, 2011, Surgical approach to and reproductive outcome after surgical correction of a T-shaped uterus, Hum Reprod, 26, 1730, 10.1093\u002Fhumrep\u002Fder056\nGarbin, 1998, Hysteroscopic metroplasty in diethylstilboestrol-exposed and hypoplastic uterus: a report on 24 cases, Hum Reprod, 13, 2751, 10.1093\u002Fhumrep\u002F13.10.2751\nMcIlwaine, 2015, A prospective study of the use of the Myosure resectoscope to manage endometrial polyps in an outpatient setting, Aust N Z J Obstet Gynaecol, 55, 482, 10.1111\u002Fajo.12382\nNoventa, 2015, Intrauterine morcellator devices: the icon of hysteroscopic future or merely a marketing image? A systematic review regarding safety, efficacy, advantages, and contraindications, Reprod Sci, 22, 1289, 10.1177\u002F1933719115578929\nScheiber, 2016, A prospective multicenter registry of patients undergoing hysteroscopic morcellation of uterine polyps and myomas, J Gynecol Surg, 32, 318, 10.1089\u002Fgyn.2016.0008\nRodriguez, 2019, Endometrial resection and ablation techniques for heavy menstrual bleeding, Cochrane Database Syst Rev\nKalampokas, 2018, Endometrial cancer after endometrial ablation or resection for menorrhagia, Int J Gynaecol Obstet, 142, 84, 10.1002\u002Fijgo.12503\nPhilip, 2018, Evaluation of NovaSure® global endometrial ablation in symptomatic adenomyosis: a longitudinal study with a 36 month-follow-up, Eur J Obstet Gynecol Reprod Biol, 227, 46, 10.1016\u002Fj.ejogrb.2018.04.001\nLou, 2019, The second generation endometrial ablation (NovaSure) improves efficacy of levonorgestrel-releasing intrauterine system in management of adenomyosis, Zhejiang Univ Med Sci, 48, 136\nThiel, 2014, Evaluation of the Novasure endometrial ablation procedure in women with uterine cavity length over 10cm, J Obstet Gynaecol Can, 36, 491, 10.1016\u002FS1701-2163(15)30562-4\nCooper, 2019, Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial, Lancet, 394, 1425, 10.1016\u002FS0140-6736(19)31790-8\nFlorio, 2012, Hysteroscopic treatment of the cesarean-induced isthmocele in restoring infertility, Curr Opin Obstet Gynecol, 24, 180, 10.1097\u002FGCO.0b013e3283521202\nCalzolari, 2019, Prevalence of infertility among patients with isthmocele and fertility outcome after isthmocele surgical treatment: a retrospective study, Ochsner J, 19, 204, 10.31486\u002Ftoj.18.0048\nMunro, 2011, The flexible FIGO classification concept for underlying causes of abnormal uterine bleeding, Semin Reprod Med, 29, 391, 10.1055\u002Fs-0031-1287663\nBettocchi, 2009, A new hysteroscopic technique for the preparation of partially intramural myomas in office setting (OPPIuM technique): a pilot study, J Minim Invasive Gynecol, 16, 748, 10.1016\u002Fj.jmig.2009.07.016\nFernandez, 2011, Update on the management of menometrorrhagia: new surgical approaches, Gynecol Endocrinol, 27, 1131, 10.3109\u002F09513590.2011.634261\nDi SpiezioSardo, 2017, The role of hysteroscopy in the diagnosis and treatment of adenomyosis, BioMed Res Int, 2017, e2518396, 10.1155\u002F2017\u002F2518396\nGeorgiou, 2018, Hysteroscopic tissue removal system (MyoSure) for the resection of polyps, sub-mucosal leiomyomas and retained products of conception in an out-patient setting: a single UK institution experience, Eur J Obstet Gynecol Reprod Biol, 231, 147, 10.1016\u002Fj.ejogrb.2018.10.030\nFaivre, 2009, Hysteroscopic management of residual trophoblastic tissue and reproductive outcome: a pilot study, J Minim Invasive Gynecol, 16, 487, 10.1016\u002Fj.jmig.2009.04.011\nRein, 2011, Hysteroscopic management of residual trophoblastic tissue is superior to ultrasound-guided curettage, J Minim Invasive Gynecol, 18, 774, 10.1016\u002Fj.jmig.2011.08.003\nGulec, 2010, Osseous metaplasia of the endometrium, BMJ Case Rep, 2010, 10.1136\u002Fbcr.04.2010.2931\nGrigore, 2018, Ultrasound features of osseous metaplasia of the endometrium – Case series and review of the literature, Clin Imaging, 52, 260, 10.1016\u002Fj.clinimag.2018.08.006\nMadaan, 2015, Osseous metaplasia of the endometrium and successful hysteroscopic resection: a report of two cases and a review of the literature, Asian J Endosc Surg, 8, 63, 10.1111\u002Fases.12153\nCarin, 2015, Intra uterine devices removal during office hysteroscopy: about 36 cases, J Gynecol Obstet Biol Reprod, 44, 653, 10.1016\u002Fj.jgyn.2014.09.005",{"ES":1304},"Histeroscopia quirúrgica",{"VOID":1306},"10.1016\u002Fs1283-081x(22)46715-4","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X22467154",[1309,1324,1336,1348],{"id":1310,"sortIndex":114,"researcher":26,"roles":1311,"affiliations":1312,"properties":1321},"f42177e7-b479-4a2e-9318-73c4c4f0608d",[696],[1313],{"id":26,"sortIndex":36,"affiliation":1314,"properties":26},{"id":1315,"createTime":1316,"updateTime":1316,"relativeEntities":1317,"slug":26,"properties":1318,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"447a96c6-b3eb-4b3c-b24e-d1019f48f79f","2024-02-12T14:44:19.701+00:00",[],{"title":1319},{"VI":1320},"Service de gynécologie obstétrique, Hôpital Bicêtre, GHU Sud, AP–HP, 78, rue du Général-Leclerc, 94270 Le Kremlin-Bicêtre, France",{"title":1322},{"VI":1323},"E. Debras",{"id":1325,"sortIndex":115,"researcher":26,"roles":1326,"affiliations":1327,"properties":1333},"1bffe931-a68d-4358-ae05-5b3497e7d37f",[696],[1328],{"id":26,"sortIndex":36,"affiliation":1329,"properties":26},{"id":1315,"createTime":1316,"updateTime":1316,"relativeEntities":1330,"slug":26,"properties":1331,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1332},{"VI":1320},{"title":1334},{"VI":1335},"S. Vigoureux",{"id":1337,"sortIndex":36,"researcher":26,"roles":1338,"affiliations":1339,"properties":1345},"4109171b-e2c5-4a04-98ac-ee4dfe0f756a",[696],[1340],{"id":26,"sortIndex":36,"affiliation":1341,"properties":26},{"id":1315,"createTime":1316,"updateTime":1316,"relativeEntities":1342,"slug":26,"properties":1343,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1344},{"VI":1320},{"title":1346},{"VI":1347},"M.-E. Neveu",{"id":1349,"sortIndex":59,"researcher":26,"roles":1350,"affiliations":1351,"properties":1377},"3ccd3418-a9dd-409e-a1c0-f1e2849ae686",[696],[1352,1362,1372],{"id":1353,"sortIndex":114,"affiliation":1354,"properties":1361},"31269e30-8572-4937-97e0-a4c30526b401",{"id":1355,"createTime":1356,"updateTime":1356,"relativeEntities":1357,"slug":26,"properties":1358,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"85ab7473-d560-4a7c-b8ee-07b3c7158319","2024-02-12T14:44:19.745+00:00",[],{"title":1359},{"VI":1360},"Centre de recherche en épidémiologie et santé des populations, Inserm, UVSQ, Université Paris-Saclay, 94807 Villejuif, France",{},{"id":1363,"sortIndex":115,"affiliation":1364,"properties":1371},"1fd9180a-6435-497b-a139-2fe7a0e28323",{"id":1365,"createTime":1366,"updateTime":1366,"relativeEntities":1367,"slug":26,"properties":1368,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"bcca5d0d-f493-42cd-8de7-5ca1467a4950","2023-12-11T17:31:33.619+00:00",[],{"title":1369},{"VI":1370},"Faculté de médecine Paris-Sud Saclay, 63, rue Gabriel-Péri, 94270 Le Kremlin-Bicêtre, France",{},{"id":26,"sortIndex":36,"affiliation":1373,"properties":26},{"id":1315,"createTime":1316,"updateTime":1316,"relativeEntities":1374,"slug":26,"properties":1375,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1376},{"VI":1320},{"title":1378},{"VI":1379},"H. Fernandez",{"url":1307,"publisher":1381,"properties":1389},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1382,"slug":662,"properties":1383,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1386,"manageAffiliations":1387,"indexDatabases":1388,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1384,"title":1385},{"VOID":665},{"EN":667},[],[],[],{"volume":1390,"pages":1392},{"VOID":1391},"58",{"VOID":1393},"1-21","2022-07-01",2022,{"id":1397,"createTime":1398,"updateTime":1399,"relativeEntities":1400,"slug":1401,"properties":1402,"entityType":688,"verifyStatus":25,"verifyTime":1399,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1409,"fullTextUrl":26,"authors":1410,"publicationType":747,"publisherRelationship":1450,"citationCount":26,"citationInfo":26,"publishDate":1394,"publishYear":1395,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"b01aff45-1715-4944-8358-bf5ecf6e69ef","2024-01-12T04:08:28.664+00:00","2024-12-05T23:50:18.874+00:00",[],"Recidiva-locorregional-del-c%C3%A1ncer-de-mama",{"references":1403,"title":1405,"doi":1407},{"VOID":1404},"Defossez G, Le Guyader-Peyrou S, Uhry Z, Grosclaude P, Colonna M, Dantony E, et al. Estimations nationales de l’incidence et de la mortalité par cancer en France métropolitaine entre 1990 et 2018. 2019. https:\u002F\u002Fwww.santepubliquefrance.fr\u002Fmaladies-et-traumatismes\u002Fcancers\u002Fcancer-du-sein\u002Fdocuments\u002Frapport-synthese\u002Festimations-nationales-de-l-incidence-et-de-la-mortalite-par-cancer-en-france-metropolitaineentre-1990-et-2018-volume-1-tumeurs-solides-etud.\nAnderson, 2009, Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer, J Clin Oncol, 27, 2466, 10.1200\u002FJCO.2008.19.8424\nAndry, 1989, Locoregional recurrences after 649 modified radical mastectomies: incidence and significance, Eur J Surg Oncol, 15, 476\nArriagada, 2002, Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer, Ann Oncol, 13, 1404, 10.1093\u002Fannonc\u002Fmdf227\nClemons, 2001, Locoregionally recurrent breast cancer: incidence, risk factors and survival, Cancer Treat Rev, 27, 67, 10.1053\u002Fctrv.2000.0204\nFortin, 1999, Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy, J Clin Oncol, 17, 101, 10.1200\u002FJCO.1999.17.1.101\nSchmoor, 2000, Role of isolated locoregional recurrence of breast cancer: results of four prospective studies, J Clin Oncol, 18, 1696, 10.1200\u002FJCO.2000.18.8.1696\nWapnir, 2006, Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials, J Clin Oncol, 24, 2028, 10.1200\u002FJCO.2005.04.3273\nTaghian, 2004, J Clin Oncol, 22, 4247, 10.1200\u002FJCO.2004.01.042\nFisher, 1991, Significance of ipsilateral breast tumour recurrence after lumpectomy, Lancet, 338, 327, 10.1016\u002F0140-6736(91)90475-5\nFisher, 1992, Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: pathological findings from NSABP protocol B-06, Semin Surg Oncol, 8, 161\nVeronesi, 1995, Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events, J Natl Cancer Inst, 87, 19, 10.1093\u002Fjnci\u002F87.1.19\nFisher, 2002, Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer, N Engl J Med, 347, 1233, 10.1056\u002FNEJMoa022152\nGalper, 2005, Prognosis after local recurrence after conservative surgery and radiation for earlystage breast cancer, Int J Radiat Oncol Biol Phys, 61, 348, 10.1016\u002Fj.ijrobp.2004.06.011\nLe, 2002, Prognostic factors for death after an isolated local recurrence in patients with early-stage breast carcinoma, Cancer, 94, 2813, 10.1002\u002Fcncr.10572\nSalvadori, 1999, Reoperation for locally recurrent breast cancer in patients previously treated with conservative surgery, Br J Surg, 86, 84, 10.1046\u002Fj.1365-2168.1999.00961.x\nClarke, 2005, Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials, Lancet, 366, 2087, 10.1016\u002FS0140-6736(05)67887-7\nBlichert-Toft, 1992, Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group, J Natl Cancer Inst Monogr, 19\nJacobson, 1995, Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer, N Engl J Med, 332, 907, 10.1056\u002FNEJM199504063321402\nSarrazin, 1989, Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer, Radiother Oncol, 14, 177, 10.1016\u002F0167-8140(89)90165-5\nvan Dongen, 2000, Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial, J Natl Cancer Inst, 92, 1143, 10.1093\u002Fjnci\u002F92.14.1143\nVeronesi, 2002, Twenty-year follow-up of a randomized study comparing breastconserving surgery with radical mastectomy for early breast cancer, N Engl J Med, 347, 1227, 10.1056\u002FNEJMoa020989\nMannino, 2009, Local relapse rates are falling after breast conserving surgery and systemic therapy for early breast cancer: can radiotherapy ever be safely withheld?, Radiotherapy and Oncology, 90, 14, 10.1016\u002Fj.radonc.2008.05.002\nHuang, 2002, Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences, Cancer, 95, 2059, 10.1002\u002Fcncr.10952\nKomoike, 2005, Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors, Breast Cancer, 12, 104, 10.2325\u002Fjbcs.12.104\nPanet-Raymond, 2011, True recurrence versus new primary: an analysis of ipsilateral breast tumor recurrences after breast-conserving therapy, Int J Radiat Oncol Biol Phys, 81, 409, 10.1016\u002Fj.ijrobp.2010.05.063\nYi, 2011, Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning, Ann Surg, 253, 572, 10.1097\u002FSLA.0b013e318208fc2a\nYoshida, 2010, True recurrences and new primary tumors have different clinical features in invasive breast cancer patients with ipsilateral breast tumor relapse after breast-conserving treatment, Breast J, 16, 127, 10.1111\u002Fj.1524-4741.2009.00884.x\nBollet, 2008, High-resolution mapping of DNA breakpoints to define true recurrences among ipsilateral breast cancers, J Natl Cancer Inst, 100, 48, 10.1093\u002Fjnci\u002Fdjm266\nVicini, 2007, The use of molecular assays to establish definitively the clonality of ipsilateral breast tumor recurrences and patterns of in-breast failure in patients with early-stage breast cancer treated with breast-conserving therapy, Cancer, 109, 1264, 10.1002\u002Fcncr.22529\nSmith, 2000, True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management, Int J Radiat Oncol Biol Phys, 48, 1281, 10.1016\u002FS0360-3016(00)01378-X\nWoodward, 2010, Among women who experience a recurrence after postmastectomy radiation therapy irradiation is not associated with more aggressive local recurrence or reduced survival, Breast Cancer Res Treat, 123, 597, 10.1007\u002Fs10549-010-0829-8\nBuchanan, 2006, Locoregional recurrence after mastectomy: incidence and outcomes, J Am Coll Surg, 203, 469, 10.1016\u002Fj.jamcollsurg.2006.06.015\nWapnir, 2008, Progress on BIG 1-02\u002FIBCSG 27-02\u002FNSABP B-37, a prospective randomized trial evaluating chemotherapy after local therapy for isolated locoregional recurrences of breast cancer, Ann Surg Oncol, 15, 3227, 10.1245\u002Fs10434-008-0129-2\nHarris, 2003, Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy, Cancer, 98, 2144, 10.1002\u002Fcncr.11767\nReddy, 2010, Long-term outcomes in patients with isolated supraclavicular nodal recurrence after mastectomy and Doxorubicin-based chemotherapy for breast cancer, Int J Radiat Oncol Biol Phys, 80, 1453, 10.1016\u002Fj.ijrobp.2010.04.015\nJaffre, 2009, Prognosis for isolated skin recurrence after breast cancer treated by mastectomy, Anticancer Res, 29, 1697\nBurstein, 2004, Ductal carcinoma in situ of the breast, N Engl J Med, 350, 1430, 10.1056\u002FNEJMra031301\nBoyages, 1999, Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis, Cancer, 85, 616, 10.1002\u002F(SICI)1097-0142(19990201)85:3\u003C616::AID-CNCR12>3.0.CO;2-7\nWapnir, 2011, Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS, J Natl Cancer Inst, 103, 478, 10.1093\u002Fjnci\u002Fdjr027\nBijker, 2006, J Clin Oncol, 24, 3381, 10.1200\u002FJCO.2006.06.1366\nFisher, 2001, Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience, Semin Oncol, 28, 400, 10.1016\u002FS0093-7754(01)90133-2\nHolmberg, 2008, Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast, J Clin Oncol, 26, 1247, 10.1200\u002FJCO.2007.12.7969\nHoughton, 2003, Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet, 362, 95\nViani, 2007, Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials, Radiat Oncol, 2, 28, 10.1186\u002F1748-717X-2-28\nSilverstein, 1999, The influence of margin width on local control of ductal carcinoma in situ of the breast, N Engl J Med, 340, 1455, 10.1056\u002FNEJM199905133401902\nSilverstein, 1996, A prognostic index for ductal carcinoma in situ of the breast, Cancer, 77, 2267, 10.1002\u002F(SICI)1097-0142(19960601)77:11\u003C2267::AID-CNCR13>3.0.CO;2-V\nWong, 2006, Prospective study of wide excision alone for ductal carcinoma in situ of the breast, J Clin Oncol, 24, 1031, 10.1200\u002FJCO.2005.02.9975\nHughes, 2009, Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group, J Clin Oncol, 27, 5319, 10.1200\u002FJCO.2009.21.8560\nMotwani, 2011, Ductal carcinoma in situ treated with breast-conserving surgery and radiotherapy: a comparison with ECOG study 5194, Cancer, 117, 1156, 10.1002\u002Fcncr.25623\nMeattini, 2017, Impact of hormonal status on outcome of ductal carcinoma in situ treated with breast-conserving surgery plus radiotherapy: long-term experience from two large-institutional series, Breast, 33, 139, 10.1016\u002Fj.breast.2017.03.017\nTay, 2020, Impact of hormonal status on ductal carcinoma in situ of the breast: outcome and prognostic factors, Breast J, 26, 937, 10.1111\u002Ftbj.13738\nWu, 2020, Recurrence outcomes after nipple-sparing mastectomy and immediate breast reconstruction in patients with pure ductal carcinoma in situ, Ann Surg Oncol, 27, 1627, 10.1245\u002Fs10434-019-08184-z\nMarinovich, 2016, The association of surgical margins and local recurrence in women with ductal carcinoma in situ treated with breast-conserving therapy: a meta-analysis, Ann Surg Oncol, 23, 3811, 10.1245\u002Fs10434-016-5446-2\nSigal-Zafrani, 2004, Histological margin assessment for breast ductal carcinoma in situ: precision and implications, Mod Pathol, 17, 81, 10.1038\u002Fmodpathol.3800019\nvan la Parra, 2019, Oncoplastic level 2 mammoplasty for large DCIS: 5-year results, Ann Surg Oncol, 26, 2459, 10.1245\u002Fs10434-019-07423-7\nKrag, 2007, Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial, Lancet Oncol, 8, 881, 10.1016\u002FS1470-2045(07)70278-4\nVeronesi, 2003, A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer, N Engl J Med, 349, 546, 10.1056\u002FNEJMoa012782\nKrag, 2010, Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial, Lancet Oncol, 11, 927, 10.1016\u002FS1470-2045(10)70207-2\nNaik, 2004, The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a followup study of 4008 procedures, Ann Surg, 240, 462, 10.1097\u002F01.sla.0000137130.23530.19\nvan der Ploeg, 2008, Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature, Eur J Surg Oncol, 34, 1277, 10.1016\u002Fj.ejso.2008.01.034\nDel Bianco, 2008, Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial, Eur J Surg Oncol, 34, 508, 10.1016\u002Fj.ejso.2007.05.017\nFisher, 1981, The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast, Surg Gynecol Obstet, 152, 765\nGoyal, 2004, Predictors of non-sentinel lymph node metastasis in breast cancer patients, Eur J Cancer, 40, 1731, 10.1016\u002Fj.ejca.2004.04.006\nHwang, 2003, Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer, Ann Surg Oncol, 10, 248, 10.1245\u002FASO.2003.05.020\nNos, 2003, Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases, Br J Surg, 90, 1354, 10.1002\u002Fbjs.4325\nAlran, 2007, Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy, Ann Surg Oncol, 14, 2195, 10.1245\u002Fs10434-006-9331-2\nCoutant, 2009, Validation of the Tenon breast cancer score for predicting nonsentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: a prospective multicenter study, Breast Cancer Res Treat, 113, 537, 10.1007\u002Fs10549-008-9967-7\nHouvenaeghel, 2009, A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis, Eur J Surg Oncol, 35, 690, 10.1016\u002Fj.ejso.2008.10.003\nKimberly, 2003, A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy, Ann Surg Oncol, 10, 1140, 10.1245\u002FASO.2003.03.015\nGrube, 2001, Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial, Semin Surg Oncol, 20, 230, 10.1002\u002Fssu.1038\nGiuliano, 2011, Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial, JAMA, 305, 569, 10.1001\u002Fjama.2011.90\nGiuliano, 2017, Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: The ACOSOG Z0011 (Alliance) randomized clinical trial, JAMA, 318, 918, 10.1001\u002Fjama.2017.11470\nGalimberti, 2018, Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year followup of a randomised, controlled phase 3 trial, Lancet Oncol, 19, 1385, 10.1016\u002FS1470-2045(18)30380-2\nde Boniface, 2017, Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial, BMC Cancer, 17, 379, 10.1186\u002Fs12885-017-3361-y\nBeadle, 2009, Ten-year recurrence rates in young women with breast cancer by locoregional treatment approach, Int J Radiat Oncol Biol Phys, 73, 734, 10.1016\u002Fj.ijrobp.2008.04.078\nTruong, 2009, Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy, Int J Radiat Oncol Biol Phys, 73, 357, 10.1016\u002Fj.ijrobp.2008.04.034\nVoogd, 2001, Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials, J Clin Oncol, 19, 1688, 10.1200\u002FJCO.2001.19.6.1688\nGentilini, 2007, When can a second conservative approach be considered for ipsilateral breast tumour recurrence?, Ann Oncol, 18, 468, 10.1093\u002Fannonc\u002Fmdl424\nOh, 2006, The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: how young is ‘young’?, Int J Radiat Oncol Biol Phys, 65, 1345, 10.1016\u002Fj.ijrobp.2006.03.028\nGarg, 2007, Effect of postmastectomy radiotherapy in patients \u003C 35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy, Int J Radiat Oncol Biol Phys, 69, 1478, 10.1016\u002Fj.ijrobp.2007.05.029\nPark, 2009, High mammographic breast density is independent predictor of local but not distant recurrence after lumpectomy and radiotherapy for invasive breast cancer, Int J Radiat Oncol Biol Phys, 73, 75, 10.1016\u002Fj.ijrobp.2008.04.007\nEwertz, 2011, Effect of obesity on prognosis after early-stage breast cancer, J Clin Oncol, 29, 25, 10.1200\u002FJCO.2010.29.7614\nGabos, 2010, The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer, Breast Cancer Res Treat, 124, 187, 10.1007\u002Fs10549-010-1135-1\nLi, 2011, Predicting breast cancer recurrence following breast-conserving therapy: a single-institution analysis consisting of 764 chinese breast cancer cases, Ann Surg Oncol, 18, 2492, 10.1245\u002Fs10434-011-1626-2\nSinn, 1998, Extensive and predominant in situ component in breast carcinoma: their influence on treatment results after breast-conserving therapy, Eur J Cancer, 34, 646, 10.1016\u002FS0959-8049(97)10106-X\nHolland, 1990, The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast, J Clin Oncol, 8, 113, 10.1200\u002FJCO.1990.8.1.113\nAlbert, 2010, Estrogen\u002Fprogesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a, bN0 breast cancer, Int J Radiat Oncol Biol Phys, 77, 1296, 10.1016\u002Fj.ijrobp.2009.12.011\nPanoff, 2011, Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation, Breast Cancer Res Treat, 128, 899, 10.1007\u002Fs10549-011-1495-1\nVoduc, 2010, Breast cancer subtypes and the risk of local and regional relapse, J Clin Oncol, 28, 1684, 10.1200\u002FJCO.2009.24.9284\nMeyers, 2011, Impact of breast cancer molecular subtypes on locoregional recurrence in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer, Ann Surg Oncol, 18, 2851, 10.1245\u002Fs10434-011-1665-8\nMontagna, 2012, Breast cancer subtypes and outcome after local and regional relapse, Ann Oncol, 23, 324, 10.1093\u002Fannonc\u002Fmdr129\nFreedman, 2009, Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation, Cancer, 115, 946, 10.1002\u002Fcncr.24094\nAlbert, 2011, Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive progesterone receptor-positive disease in very early stage breast cancer, Cancer, 117, 1595, 10.1002\u002Fcncr.25694\nWapnir, 2018, Efficacy of chemotherapy for ER-Negative and ER-Positive isolated locoregional recurrence of breast cancer: final analysis of the CALOR trial, J Clin Oncol, 36, 1073, 10.1200\u002FJCO.2017.76.5719\nPan, 2017, 20-Year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years, N Engl J Med, 377, 1836, 10.1056\u002FNEJMoa1701830\nLowery, 2012, Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype, Breast Cancer Res Treat, 133, 831, 10.1007\u002Fs10549-011-1891-6\nZumsteg, 2013, Breast-conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1-2N0 triple-negative breast cancer, Ann Surg Oncol, 20, 3469, 10.1245\u002Fs10434-013-3011-9\nChen, 2017, Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer, Adv Radiat Oncol, 2, 105, 10.1016\u002Fj.adro.2017.01.012\nWang, 2010, Triplenegative or HER2-positive status predicts higher rates of locoregional recurrence in node-positive breast cancer patients after mastectomy, Int J Radiat Oncol Biol Phys, 80, 1095, 10.1016\u002Fj.ijrobp.2010.03.038\nKwan, 2010, Does HER2 status influence locoregional failure rates in breast cancer patients treated with mastectomy for pT1-2pN0 disease?, Ann Oncol, 21, 988, 10.1093\u002Fannonc\u002Fmdp396\nMamounas, 2010, Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20, J Clin Oncol, 28, 1677, 10.1200\u002FJCO.2009.23.7610\nMamounas, 2017, 21-Gene recurrence score and locoregional recurrence in nodepositive\u002Fer-positive breast cancer treated with chemo-endocrine therapy, J Natl Cancer Inst, 109, 10.1093\u002Fjnci\u002Fdjw259\nTurashvili, 2017, 21-Gene recurrence score and locoregional recurrence in lymph nodenegative, estrogen receptor-positive breast cancer, Breast Cancer Res Treat, 166, 69, 10.1007\u002Fs10549-017-4381-7\nBidard, 2009, Disseminated tumor cells and the risk of locoregional recurrence in nonmetastatic breast cancer, Ann Oncol, 20, 1836, 10.1093\u002Fannonc\u002Fmdp200\nHoussami, 2010, Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy, Eur J Cancer, 46, 3219, 10.1016\u002Fj.ejca.2010.07.043\nAziz, 2006, The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer, Breast J, 12, 331, 10.1111\u002Fj.1075-122X.2006.00271.x\nChagpar, 2004, Lumpectomy margins are affected by tumor size and histologic subtype but not by biopsy technique, Am J Surg, 188, 399, 10.1016\u002Fj.amjsurg.2004.06.020\nMoore, 2000, Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservation therapy, Ann Surg, 231, 877, 10.1097\u002F00000658-200006000-00012\nvan Deurzen, 2016, Predictors of surgical margin following breastconserving surgery: a large population-based cohort study, Ann Surg Oncol, 23, 627, 10.1245\u002Fs10434-016-5532-5\nPleijhuis, 2013, A validated web-based nomogram for predicting positive surgical margins following breast-conserving surgery as a preoperative tool for clinical decision-making, Breast, 22, 773, 10.1016\u002Fj.breast.2013.01.010\nHeil, 2012, Do reexcisions impair aesthetic outcome in breast conservation surgery? Exploratory analysis of a prospective cohort study, Ann Surg Oncol, 19, 541, 10.1245\u002Fs10434-011-1947-1\nGagliato Dde, 2014, Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer, J Clin Oncol, 32, 735, 10.1200\u002FJCO.2013.49.7693\nHennigs, 2016, Do patients after reexcision due to involved or close margins have the same risk of local recurrence as those after one-step breast-conserving surgery?, Ann Surg Oncol, 23, 1831, 10.1245\u002Fs10434-015-5067-1\nHolland, 1985, Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery, Cancer, 56, 979, 10.1002\u002F1097-0142(19850901)56:5\u003C979::AID-CNCR2820560502>3.0.CO;2-N\nFitzgerald, 2016, Close and positive lumpectomy margins are associated with similar rates of residual disease with additional surgery, Ann Surg Oncol, 23, 4270, 10.1245\u002Fs10434-016-5490-y\nGarvey, 2015, Rates of residual disease with close but negative margins in breast cancer surgery, Breast, 24, 413, 10.1016\u002Fj.breast.2015.03.005\nDemirci, 2012, Breast conservation therapy: the influence of molecular subtype and margins, Int J Radiation Oncol Biol Physics, 83, 814, 10.1016\u002Fj.ijrobp.2011.09.001\nJones, 2009, Impact of pathological characteristics on local relapse after breastconserving therapy: a subgroup analysis of the EORTC boost versus no boost trial, J Clin Oncol, 27, 4939, 10.1200\u002FJCO.2008.21.5764\nHoussami, 2014, The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis, Ann Surg Oncol, 21, 717, 10.1245\u002Fs10434-014-3480-5\nMoran, 2014, Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer, J Clin Oncol, 32, 1507, 10.1200\u002FJCO.2013.53.3935\nVaidya, 2020, Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial, BMJ, 370\nCuzick, 2011, Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK\u002FANZ DCIS trial, Lancet Oncol, 12, 21, 10.1016\u002FS1470-2045(10)70266-7\nPetrelli, 2011, Tamoxifen added to radiotherapy and surgery for the treatment of ductal carcinoma in situ of the breast: a meta-analysis of 2 randomized trials, Radiother Oncol, 100, 195, 10.1016\u002Fj.radonc.2011.02.005\nMauri, 2005, Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis, J Natl Cancer Inst, 97, 188, 10.1093\u002Fjnci\u002Fdji021\nBuzdar, 2005, Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer, J Clin Oncol, 23, 3676, 10.1200\u002FJCO.2005.07.032\nLiedtke, 2008, Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer, J Clin Oncol, 26, 1275, 10.1200\u002FJCO.2007.14.4147\nChen, 2004, Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience, J Clin Oncol, 22, 2303, 10.1200\u002FJCO.2004.09.062\nBroecker, 2017, Neoadjuvant therapy combined with oncoplastic reduction for high-stage breast cancer patients, Ann Plast Surg, 78, S258, 10.1097\u002FSAP.0000000000001062\nMazouni, 2013, The role of oncoplastic breast surgery in the management of breast cancer treated with primary chemotherapy, Breast, 22, 1189, 10.1016\u002Fj.breast.2013.07.055\nAlpert, 2005, Ipsilateral breast tumor recurrence after breast conservation therapy: outcomes of salvage mastectomy vs. salvage breast-conserving surgery and prognostic factors for salvage breast preservation, Int J Radiat Oncol Biol Phys, 63, 845, 10.1016\u002Fj.ijrobp.2005.02.035\nSchnitt, 1985, Breast relapse following primary radiation therapy for early breast cancer. II. Detection, pathologic features and prognostic significance, Int J Radiat Oncol Biol Phys, 11, 1277, 10.1016\u002F0360-3016(85)90242-1\nKurtz, 1991, Is breast conservation after local recurrence feasible?, Cancer, 27, 240\nVoogd, 1999, Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local recurrence after breast conservation (BORST), Eur J Cancer, 35, 1828, 10.1016\u002FS0959-8049(99)00220-8\nSellam, 2019, Local recurrence of breast cancer: salvage lumpectomy as an option for local treatment, Breast J, 25, 619, 10.1111\u002Ftbj.13290\nKuerer, 2004, Repeat breast-conserving surgery for in-breast local breast carcinoma recurrence: the potential role of partial breast irradiation, Cancer, 100, 2269, 10.1002\u002Fcncr.20257\nDeutsch, 2002, Repeat high-dose external beam irradiation for in-breast tumor recurrence after previous lumpectomy and whole breast irradiation, Int J Radiat Oncol Biol Phys, 53, 687, 10.1016\u002FS0360-3016(02)02785-2\nChadha, 2008, The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer, Brachytherapy, 7, 22, 10.1016\u002Fj.brachy.2007.10.006\nHannoun-Levi, 2013, Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: multicentric study of the GEC-ESTRO Breast Cancer Working Group, Radiother Oncol, 108, 226, 10.1016\u002Fj.radonc.2013.03.026\nHannoun-Levi, 2011, Second conservative treatment for ipsilateral breast cancer recurrence using high-dose rate interstitial brachytherapy: preliminary clinical results and evaluation of patient satisfaction, Brachytherapy, 10, 171, 10.1016\u002Fj.brachy.2010.05.004\nHannoun-Levi, 2004, Partial breast irradiation as second conservative treatment for local breast cancer recurrence, Int J Radiat Oncol Biol Phys, 60, 1385, 10.1016\u002Fj.ijrobp.2004.05.035\nResch, 2002, Locally recurrent breast cancer: pulse dose rate brachytherapy for repeat irradiation following lumpectomy. a second chance to preserve the breast1, Radiology, 225, 713, 10.1148\u002Fradiol.2253011913\nTrombetta, 2008, Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience, Brachytherapy, 7, 29, 10.1016\u002Fj.brachy.2007.12.001\nVavassori, 2020, High-dose-rate Brachytherapy as Adjuvant Local rEirradiation for Salvage Treatment of Recurrent breAst cancer (BALESTRA): a retrospective mono-institutional study, J Contemp Brachytherapy, 12, 207, 10.5114\u002Fjcb.2020.96860\nKuo, 2008, Comprehensive locoregional treatment and systemic therapy for postmastectomy isolated locoregional recurrence, Int J Radiat Oncol Biol Phys, 72, 1456, 10.1016\u002Fj.ijrobp.2008.03.042\nMaaskant-Braat, 2013, Repeat sentinel node biopsy in patients with locally recurrent breast cancer: a systematic review and meta-analysis of the literature, Breast Cancer Res Treat, 138, 13, 10.1007\u002Fs10549-013-2409-1\nVugts, 2015, Improving the success rate of repeat sentinel node biopsy in recurrent breast cancer, Ann Surg Oncol, 22, S529, 10.1245\u002Fs10434-015-4787-6\nVugts, 2015, Repeat sentinel node biopsy should be considered in patients with locally recurrent breast cancer, Breast Cancer Res Treat, 153, 549, 10.1007\u002Fs10549-015-3571-4\nBeck, 1983, Local or regionally recurrent carcinoma of the breast: results of therapy in 121 patients, J Clin Oncol, 1, 400, 10.1200\u002FJCO.1983.1.6.400\nHalverson, 1992, Locoregional recurrence of breast cancer: a retrospective comparison of irradiation alone versus irradiation and systemic therapy, Am J Clin Oncol, 15, 93, 10.1097\u002F00000421-199204000-00001\nJanjan, 1986, Management of locoregional recurrent breast cancer, Cancer, 58, 1552, 10.1002\u002F1097-0142(19861001)58:7\u003C1552::AID-CNCR2820580728>3.0.CO;2-W\nRauschecker, 2001, Systemic therapy for treating locoregional recurrence in women with breast cancer, Cochrane Database Syst Rev, CD002195\nWaeber, 2003, Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: definitive results of a phase III randomized trial (SAKK 23\u002F82) comparing tamoxifen with observation, Ann Oncol, 14, 1215, 10.1093\u002Fannonc\u002Fmdg347",{"ES":1406},"Recidiva locorregional del cáncer de mama",{"VOID":1408},"10.1016\u002Fs1283-081x(22)46718-x","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X2246718X",[1411,1426,1438],{"id":1412,"sortIndex":115,"researcher":26,"roles":1413,"affiliations":1414,"properties":1423},"5635d257-5426-4a90-918d-397a90d7f98a",[696],[1415],{"id":26,"sortIndex":36,"affiliation":1416,"properties":26},{"id":1417,"createTime":1418,"updateTime":1418,"relativeEntities":1419,"slug":26,"properties":1420,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"a40fbfc9-f226-4942-b18d-08639538be21","2024-01-12T04:08:28.851+00:00",[],{"title":1421},{"VI":1422},"Département de chirurgie oncologique, ICM Val d’Aurelle, rue de la Croix-Verte, 34298 Montpellier, France",{"title":1424},{"VI":1425},"C. Taoum",{"id":1427,"sortIndex":36,"researcher":26,"roles":1428,"affiliations":1429,"properties":1435},"088b5668-ccf2-4ccc-9e1f-710a39ebbf98",[696],[1430],{"id":26,"sortIndex":36,"affiliation":1431,"properties":26},{"id":1417,"createTime":1418,"updateTime":1418,"relativeEntities":1432,"slug":26,"properties":1433,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1434},{"VI":1422},{"title":1436},{"VI":1437},"P.-E. Colombo",{"id":1439,"sortIndex":114,"researcher":26,"roles":1440,"affiliations":1441,"properties":1447},"997809e6-5134-4187-8c55-2df934ca2a6c",[696],[1442],{"id":26,"sortIndex":36,"affiliation":1443,"properties":26},{"id":1417,"createTime":1418,"updateTime":1418,"relativeEntities":1444,"slug":26,"properties":1445,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1446},{"VI":1422},{"title":1448},{"VI":1449},"P. Rouanet",{"url":1409,"publisher":1451,"properties":1459},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1452,"slug":662,"properties":1453,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1456,"manageAffiliations":1457,"indexDatabases":1458,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1454,"title":1455},{"VOID":665},{"EN":667},[],[],[],{"volume":1460,"pages":1461},{"VOID":1391},{"VOID":1462},"1-20"]